WO2007021008A1 - Process for producing plaster, apparatus for producing the same, and liner for plaster - Google Patents

Process for producing plaster, apparatus for producing the same, and liner for plaster Download PDF

Info

Publication number
WO2007021008A1
WO2007021008A1 PCT/JP2006/316266 JP2006316266W WO2007021008A1 WO 2007021008 A1 WO2007021008 A1 WO 2007021008A1 JP 2006316266 W JP2006316266 W JP 2006316266W WO 2007021008 A1 WO2007021008 A1 WO 2007021008A1
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
base layer
adhesive base
liner
temperature
Prior art date
Application number
PCT/JP2006/316266
Other languages
French (fr)
Japanese (ja)
Inventor
Shinji Morikane
Daizo Morikane
Original Assignee
Dia Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dia Pharmaceutical Co., Ltd. filed Critical Dia Pharmaceutical Co., Ltd.
Priority to JP2007531044A priority Critical patent/JP4913738B2/en
Publication of WO2007021008A1 publication Critical patent/WO2007021008A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/58Adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Definitions

  • the present invention relates to a plaster manufacturing method and a manufacturing apparatus therefor, and more specifically, a support, a pressure-sensitive adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order.
  • the present invention relates to a plaster manufacturing method and a manufacturing apparatus for manufacturing a plaster.
  • Plaster is known as a medical pressure-sensitive adhesive tape, adhesive bandage, patch, and the like.
  • Typical examples of the plaster include a support, a pressure-sensitive adhesive layer spread on one surface, and the pressure-sensitive adhesive. And a liner that is releasably adhered to the layer.
  • Examples of the pressure-sensitive adhesive include natural rubber, synthetic rubber and a mixture thereof, an acrylic polymer solution emulsion type, a hot melt type, and an electron beam curable type.
  • a method of mixing the active ingredient in the adhesive and applying it to a support is common (for example, Patent Document 1). reference).
  • Patent Document 1 JP-A-8-295624
  • the present invention has been made in order to solve the above-described problems, and can be efficiently contained or supported in an adhesive layer without reducing the activity of an active ingredient. Further, the present invention provides a method for producing a plaster and an apparatus for producing the same, which can prevent the seepage of the adhesive base even if a permeable support is used.
  • the inventors of the present invention have made extensive studies to solve the above problems, and obtained the knowledge that the active ingredient can be contained in the adhesive base layer even after formation of the adhesive base layer. Based on this knowledge, an adhesive base layer that does not contain an active ingredient is first formed, and then the adhesive base layer is brought to a temperature condition that does not reduce the activity of the active ingredient and then the active ingredient is contained. Has been found to be able to solve the problem, and the present invention has been completed.
  • one feature of the present invention is a method for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order, the support or liner
  • the adhesive base layer is formed by heating according to the type of the adhesive and melting the adhesive itself or evaporating the solvent used, and containing or carrying the effective component in the adhesive base layer. Consisting of continuously obtaining plaster,
  • the active ingredient is contained or supported on the adhesive base layer in a state where the heating temperature at the time of forming the adhesive base layer is lowered to a temperature that does not reduce the activity of the active ingredient.
  • a further feature of the present invention is that when the adhesive base layer is formed on the support or liner, and the active ingredient is contained or supported on the adhesive base layer, the heating temperature of the adhesive base layer is determined as the active ingredient. However, it does not reduce the temperature of the adhesive base layer unilaterally, but the active ingredient is contained in the adhesive base layer at a higher temperature.
  • the temperature of the active ingredient contained or supported in the adhesive base layer should not be lowered, the temperature Is a force depending on the active ingredient, for example, about 130 ° C or less, preferably about 35 to about 100 ° C, and more preferably about 35 to about 80 ° C.
  • the temperature at which the activity of the active ingredient is not lowered can be obtained by temperature detecting means for detecting the temperature of the adhesive base layer. Although not particularly limited, for example, it can be obtained by a non-contact infrared thermosensor that detects the temperature of the surface of the adhesive base layer.
  • the active ingredient is contained or supported in the adhesive base layer means that the active ingredient is contained (impregnated or penetrated) in the adhesive base layer, or the active ingredient is completely supported on the surface of the adhesive base layer.
  • the case where a part of the active ingredient is contained in the adhesive base layer and the rest is supported on the surface of the adhesive base layer is also included.
  • Formation of the pressure-sensitive adhesive layer containing or carrying the active ingredient includes (1) forming an adhesive base layer on the support and forming an active ingredient-containing layer containing the active ingredient on the liner, The active ingredient-containing layer is bonded together in a state where the temperature of the adhesive base layer formed on the support is lowered to a desired temperature, or (2) of the adhesive base layer formed on the support It is obtained by applying a solution in which an active ingredient is dissolved or dispersed on the adhesive base layer in a state where the temperature is lowered to a desired temperature.
  • the present invention provides an apparatus for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order.
  • the active ingredient carrying layer is bonded to the surface of the adhesive base layer, and the active ingredient is attached to the adhesive base. Contained in the layer Possible to provide a manufacturing apparatus of plaster comprising a bonding means to the adhesive base layer and the effective component carrying layer is to be carried.
  • the present invention is an apparatus for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order.
  • an adhesive base layer is formed in advance on the support or liner by melting or evaporating the solvent according to the type of the adhesive, and thereafter, an effective component is formed on the adhesive base layer.
  • the heating temperature of the adhesive base layer is lowered to a temperature condition that does not reduce the activity of the active ingredient.
  • the temperature of the adhesive base layer is not lowered.
  • the active ingredient is contained or supported on the adhesive base layer at a higher temperature, thereby effectively containing the active ingredient in the adhesive base layer.
  • Support use high permeability at high temperature, and make sure that the liner and support force can be firmly bonded in the process of forming the adhesive base layer. Unnecessarily reducing waste and reducing time, and improving the quality and productivity of plasters.
  • FIG. 1 is a schematic configuration explanatory view showing a first embodiment of a plaster manufacturing apparatus according to the present invention.
  • FIG. 2 is a cross-sectional view illustrating a schematic configuration of the plaster manufactured in Embodiment 1 of FIG.
  • FIG. 3 is a schematic configuration explanatory view showing Embodiment 2 of a plaster manufacturing apparatus according to the present invention. is there.
  • FIG. 4 is a cross-sectional view illustrating the schematic configuration of the plaster manufactured in the second embodiment shown in FIG. Explanation of symbols
  • a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order, and the liner is peeled off during use from the adhesive layer side.
  • the plaster to be attached to the surface to be applied is the manufacturing target.
  • an adhesive base layer (meaning an adhesive layer not containing an active ingredient) is first formed on a support or liner, and the activity of the active ingredient is reduced in the adhesive base layer.
  • the active ingredient is contained or supported under temperature conditions that do not.
  • the material and shape of the support those known in the art can be used. More specifically, as the raw material for producing the plaster, a sheet or a film is used, which is cut into an appropriate size after the plaster is formed.
  • the material may be any of non-woven fabrics and woven fabrics made of natural fibers, synthetic resin fibers, and other synthetic resin films.
  • non-woven fabrics formed into a cloth using one or more types of fibers such as polyester, polypropylene, or rayon.
  • Preferable examples include woven fabric made of polyester fiber, sufumuslin, a chlorinated bure film, a polyethylene film, a polyurethane / vinyl chloride copolymer film, and a polyurethane film that are woven using soot.
  • cellophane cellulose acetate, polyvinylidene chloride, nitrile rubber, polypropylene homo or copolymer, polyamide, polytetrafluoroethylene, and other synthetic resins, and blends with other polymers can also be listed as preferred materials.
  • S a support that is not limited to these, is selected depending on the application.
  • Examples of the liner include paper and films processed on both sides having releasability, crepe paper, embossed films, and films coated with other release agents.
  • Examples of the film include a vinyl chloride film, a polyethylene film, a polypropylene film, a polyester film, and a polyethylene terephthalate film. Of particular importance are silicone release liners wherein the film is silicone treated.
  • Examples of the pressure-sensitive adhesive forming the pressure-sensitive adhesive base layer include natural rubber, synthetic rubber and a mixture thereof, a solution-based emulsion type of acrylic polymer, a hot melt type, and an electron beam curable type ( Published by Nikkan Kogyo Shimbun, “Adhesion Technology No. Book” pages 774-775). These pressure-sensitive adhesives have different methods for forming a pressure-sensitive adhesive base layer depending on their types. In any of these methods, the adhesive base layer is formed through a high temperature. Therefore, in the present invention, when the adhesive base layer does not decrease the activity of the active ingredient, (when the temperature is high) The active ingredient is contained or supported after adjusting to a temperature condition that does not reduce the activity of the active ingredient.
  • the penetration of the active ingredient into the adhesive base layer can be made effective, or the other liner can be supported or supported.
  • Hot-melt adhesives are heated to a high temperature (for example, 120 to 180 ° C) and melted, and an adhesive base layer is formed on either the support or liner by spreading or coating (coating).
  • the adhesive base layer contains or carries the active ingredient under temperature conditions that do not reduce the activity of the active ingredient, but the temperature is higher than the temperature conditions that do not reduce the activity of the active ingredient.
  • the active ingredient is contained in the adhesive base layer under certain conditions, whereby the active ingredient is effectively infiltrated into the adhesive base layer (use of high permeability at high temperature), and either the support or the liner (especially (Liner) can be tightly bonded (use of high tack at high temperatures), and in particular, in industrial production, unnecessary waste of temperature reduction can be eliminated.
  • examples of the hot-melt rubber-based pressure-sensitive adhesive include a combination of the following elastomer and a tackifier. That is, as an elastomer, natural rubber, synthetic polyisoprene rubber, styrene-butadiene rubber, styrene-isoprene block copolymer, polyisobutylene, butyl rubber, styrene-isoprene-styrene block copolymer (abbreviated as SIS). The same applies hereinafter), styrene butadiene rubber (SBR), hydrogen additive of styrene butadiene rubber (SBRS), and the like.
  • SBR styrene butadiene rubber
  • SBRS hydrogen additive of styrene butadiene rubber
  • Tackifiers include rosin, hydrogenated rosin, rosin ester, hydrogenated rosin ester, polytenolene, terpene phenol, phenol resin, xylene resin, coumarone indene resin, and other aliphatic resins (C5 resin). , Petroleum resins, alicyclic hydrocarbon resins (hydrogenated aromatic resins), and the like.
  • a rubber-based pressure-sensitive adhesive in which these elastomers and a tackifier are combined can be made into a solid block at room temperature, and heated by heating to a high temperature (for example, 120 to 180 ° C). And then spread (apply) directly on the support or liner to form an adhesive base layer. Separately spread (apply) on a roll or the like to form an adhesive base layer. After pressing, the adhesive base layer may be attached (transferred) on the support or liner.
  • the thickness of the pressure-sensitive adhesive layer is generally set to 10 to 1000 zm, preferably 20 to 200 zm in consideration of securing the adhesive strength of the plaster and the retention strength of the active ingredient.
  • the adhesive With solvent-type adhesives, the adhesive is spread or applied (coating) by dissolving it in a solvent, and then the solvent is evaporated at a high temperature (for example, 120 ° C) to either the support or the liner.
  • a high temperature for example, 120 ° C
  • An adhesive base layer is formed.
  • the adhesive base layer contains or carries the active ingredient under a temperature condition that does not reduce the activity of the active ingredient, but the temperature condition does not reduce the activity of the active ingredient at a higher temperature condition.
  • the active ingredient is contained or supported on the adhesive base layer, so that the active ingredient can effectively penetrate into the adhesive base layer (use of high permeability at high temperature) and support It is possible to firmly attach either the body or the liner (especially the liner) in the process of forming the adhesive base layer, and it is possible to eliminate the waste of lowering the temperature unnecessarily, especially in industrial production. .
  • examples of the solvent-type acrylic pressure-sensitive adhesive include combinations of the following main monomers and submonomers. That is, as the main monomer, ethyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, octyl acrylate, isooctyl acrylate, decyl acrylate, decyl methacrylate, dodecyl acrylate, dodecyl methacrylate, etc. Is mentioned.
  • examples of the secondary monomer include acrylic acid, butyl acetate, methyl acrylate, methyl methacrylate, maleic anhydride, and 2-hydroxyethyl acrylate.
  • the acrylic pressure-sensitive adhesive combining the main monomer and the submonomer is appropriately added with an additive, dissolved in a specific solvent, coated (spread or coated) on a support or liner, and then heated (for example, 120). ° C) through a drying tunnel to properly evaporate the solvent and An agent layer is formed.
  • a softener plasticizer
  • an absorption accelerator polyhydric alcohols
  • silicone oils silicone oils
  • inorganic fillers antioxidants (ultraviolet absorbers) and the like are appropriately used for the adhesive base layer.
  • an active ingredient together with a softening agent (plasticizer) of a low molecular compound that can dissolve or disperse the active ingredient and penetrate into the adhesive base layer.
  • softener examples include polybutene, polyisobutylene, dioctyl phthalate, dibutyl phthalate, jetyl phthalate, liquid rosin ester, chlorinated paraffin, process oil, lanolin, IPM, silicone, petrolatum, solid Paraffin, liquid paraffin, plastic pace, beeswax, mentholenole, limonene, binene, piperiton, terpinol, carveol, almond oil, olive oil, camellia oil, persic oil, hearth oil, sesame oil, soybean oil, mink oil, Cottonseed oil, corn oil, safflower oil, grape oil, macadamia nut oil, egg yolk oil, safflower oil, crotamiton, pyrrolidone, liquid polyisoprene, medium chain fatty acid triglyceride, polyethylene glycol, benzyl alcohol, oleyl alcohol, dimethyl alcohol
  • polyhydric alcohol examples include glycerin, propylene glycol, octanediol, polyethylene glycol, D-sorbit, crotamiton and the like.
  • silicone oil examples include methylsiloxane, methylphenylpolysiloxane, dodecamethylpolysiloxane, and the like.
  • examples of the inorganic filler include zinc oxide, titanium oxide, and calcium carbonate.
  • examples of the antioxidant (ultraviolet absorber) include BHT and DTBHQ.
  • Effective composition suitable for inclusion or support in the adhesive base layer of the plaster according to the present invention examples include the following pharmaceutical ingredients (pharmaceuticals), cosmetic ingredients (cosmetics), and fragrances.
  • Pharmaceutical components (pharmaceuticals) include anti-inflammatory analgesics, hormonal agents, local anesthetics, nitrates for heart disease, therapeutic agents for motion sickness, therapeutic agents for menopause, antihypertensive agents, cancer pain relieving agents, bronchodilators, smoking cessation aids , Urinary incontinence treatment, etc., and specific examples include ferpinac, indomethacin, ketoprofen, flurbiprofen, methyl salicylate, glycol salicylate, mentholore, betamethasone valerate, insulin, lidocaine ( MT66 ⁇ 6 9 ° C, BT159 ⁇ : 160 ° C), isosorbide nitrate, nitroglycerin (stable at 50 ° C or less), sco
  • cosmetic ingredients include vitamins, moisturizers, whitening agents, blood circulation promoting ingredients, antioxidant ingredients, cell activation ingredients, antiallergic ingredients, and the like.
  • examples include, but are not limited to, C, vitamin E, arbutin, and ubidecarenone.
  • the temperature at which the activity of the active ingredient is not reduced is, for example, 45 ° C. or less for the cell activation ingredient ubidecaren.
  • fragrance examples include sweet orange, lemon, bergamot, peppermint, lavender, geranium, rose, jasmine, basil, eucalyptus, and the like, but are not limited to these.
  • the active ingredient as described above is applied, it is used in a solution in which the active ingredient is dissolved or dispersed in an appropriate medium.
  • the medium is selected mainly considering the physical properties such as solubility in organic solvents and water depending on the type of active ingredient, but in addition, it is compatible with the adhesive base layer.
  • the use of a compatible medium is preferable for containing or penetrating the active ingredient in the adhesive base layer at a high concentration. A person skilled in the art can easily select the medium without the need for special experimentation.
  • the above-mentioned softeners can be used singly or in combination according to the active ingredient.
  • crotamiton is preferably used for pharmaceutical ingredients such as ketoprofen, ibuprofen, lidocaine, flurbiprofen, aspirin, felbinac, and pyrrolidone is used for ketoprofen, ibuprofen, lidocaine, felpinac, diclofenac sodium
  • Isopropanolamine is preferably used for pharmaceutical ingredients such as ketoprofen, ibuprofen, lidocaine, flurbiprofen, and aspirin. It is preferably used for pharmaceutical ingredients such as oral fen, lidocaine, flurbiprofen and the like. However, it is not limited to these.
  • the active ingredient-containing layer used for bonding with the adhesive base layer allows the active ingredient to be supported uniformly and at an appropriate concentration on an appropriate liquid or solid carrier (a solvent is added if necessary). Let it form.
  • the liquid or solid carrier is preferably one that is inert to the active ingredient and can be easily removed after bonding with the adhesive base layer or does not substantially remain. This is also the softener (plasticizer) described above. Can be used alone or as a mixture of two or more thereof depending on the active ingredient.
  • the following temperature adjusting means can be appropriately employed.
  • Adhesive base layer forming means comprising: an adhesive base layer forming roll in which the supplied high-temperature adhesive is spread on the roll surface to form an adhesive base layer; It is composed of a laminating roll for laminating the pressure-sensitive adhesive base layer on either one, and a cooler for lowering the temperature of the pressure-sensitive adhesive base layer to a temperature that does not decrease the activity of the active ingredient is heated on this laminating roll.
  • a cooling chamber is provided by passing through the layer to lower at least the temperature of the adhesive base layer to a temperature that does not decrease the activity of the active ingredient.
  • the temperature adjusting means is unnecessary.
  • the adhesive base layer is formed on the support and the active ingredient-containing layer is formed on the liner, respectively.
  • the active ingredient-containing layer is bonded to the adhesive base layer formed on the body.
  • An adhesive base layer may be formed on the liner, an active ingredient-containing layer may be formed on the support, and the active ingredient-containing layer may be bonded to the adhesive base layer formed on the liner.
  • an adhesive base layer may be formed on a support or liner, and a solution in which an active ingredient is dissolved or dispersed may be spread or applied (coated) on the adhesive base layer.
  • a solution in which an active ingredient is dissolved or dispersed may be spread or applied (coated) on the adhesive base layer. Examples of the application include roll method and spray method.
  • an active ingredient that can permeate (transfer or impregnate) the adhesive base layer by the above-mentioned bonding or coating, and can be contained or supported is selected and used.
  • the active ingredient permeates and diffuses into the adhesive base layer from the active ingredient carrying layer brought into contact with the adhesive base layer by bonding or coating, thereby forming an adhesive layer containing the active ingredient almost evenly.
  • the obtained plaster has a structure in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order.
  • the liner is peeled off during use, and the plaster is peeled off. It is applied to the desired skin surface from the coated surface side (adhesive layer). Further, if necessary, the concentration distribution of the active ingredient in the adhesive base layer can be increased with the liner ⁇ J.
  • FIG. 1 is a schematic structural explanatory view showing Embodiment 1 of a plaster manufacturing apparatus according to the present invention
  • FIG. 2 is a schematic structural explanatory sectional view of a plaster.
  • plaster P1 includes a support 2 and an adhesive layer 4 containing an active ingredient.
  • the liner 3 is laminated in this order, and the liner 3 is peeled off during use, and the adhesive layer 4 can be applied to the surface to be applied (skin surface) (for example, the overall size: approximately 70 mm). X about 100mm).
  • the support 2 is made of a non-woven fabric made of polyester (support thickness: approximately 1 mm).
  • Liner 3 is made of a peelable synthetic resin sheet with appropriate release agent applied to PET (liner thickness: about 30-60 111).
  • Adhesive layer 4 contains a hormonal agent (insulin) (about 400 ⁇ g) as an active ingredient in styrene-isoprene-styrene resin (SIS), which is a rubber adhesive as a hot-melt adhesive. (The thickness of the pressure-sensitive adhesive layer: about 100 to 200 ⁇ m).
  • the plaster manufacturing apparatus 1 includes a support transport means for transporting the support 2 from the support feed roll 6, a liner transport means for transporting the liner 3 from the liner feed roll 10, and Adhesive base layer forming means for forming the adhesive base layer 4a on the transported support 2; Pharmaceutical component support layer forming means for forming the pharmaceutical ingredient supporting layer 5 on the liner 3 to be transported; 2 on the adhesive base layer 4a formed on 2 is bonded from the side of the pharmaceutical component support layer 5 to the liner 3 and the pharmaceutical component support layer 5 formed thereon, and is a plaster P1; And plaster removing means for scraping the plaster P1 obtained by the bonding means.
  • the support transport means includes a no-tension transport roll 7 for supplying the support 2 fed from the support feed roll 6 to an adhesive base layer forming main roll 14 described later with no tension, and the transport roll. It consists of a guide roll 8 between the main roll 14.
  • the liner conveying means includes a guide roll 11 that feeds the liner 3 from the liner feed roll 10 and guides and feeds it to a rubber roll 17 described later.
  • the adhesive base layer forming means includes a comma coater 19 having a first roll 9 and a second roll 12 having a temperature control function, a cooling roll 13 having a roll-coated silicon surface, and the cooling roll. And a main base 14 for forming an adhesive base layer which is in contact with the surface of the roll and is anti-slip processed.
  • the cooling roll 13 is provided with a cooler (not shown) that is attached in a heat exchange manner and reduces the temperature of the adhesive base layer 4a formed on the roll surface to a temperature that does not reduce the activity of the pharmaceutical ingredients. Yes.
  • the medicinal component-supporting layer forming means comprises a container 15 for storing a medicinal component solution, a gravure roll 16 partially immersed in the medicinal component solution in the container, and a gravure roll in contact with the gravure roll. It comprises a rubber roll 17 that forms a medicinal component-supporting layer 5 on a liner 3 that passes through the gap.
  • Reference numeral 23 denotes a gravure roll 16 scraper.
  • the laminating means comprises a sub roll 18 that contacts the main roll 14.
  • the plaster scraping means includes a scraper opening 20 for scraping the plaster P1 by a torque motor (not shown), and two guide rolls 21 and 22.
  • the support feeding roll 6 supplies the support 2 to the main roll 14 for forming the adhesive base layer with no tension via the no tension conveying roll 7 and the guide roll 8.
  • the first roll 9 and the second roll 12 are supplied with the SIS pressure-sensitive adhesive that has been heated to 160 to 180 ° C. from the solid state to become a molten state, and the molten SIS pressure-sensitive adhesive 120 to 160: 160 While adjusting the temperature to ° C, supply it to the cooling roll 13 and spread it at a thickness of about 100 ⁇ .
  • the cooling roller 13 forms an adhesive base layer 4a on the support 2 supplied to the main roller 14 while lowering the temperature of the spread SIS resin to about 2 to 8 ° C.
  • An infrared sensor (not shown) that detects the surface temperature of the adhesive base layer 4a formed on the support 2 is provided, and a temperature signal detected by this sensor is sent to the temperature of the cooler via a controller (not shown). It is comprised so that it may control.
  • the liner feeding roll 10 supplies the liner 3 to the rubber roll 17 through the guide roll 11, and the gravure roll 16 transfers the pharmaceutical ingredient solution (insulin dissolved in lanolin) in the container 15 onto the rubber roll 17.
  • the medicine component carrying layer 5 is formed by spreading on the surface of the liner 3.
  • the main roll 14 and the sub-roll 18 are bonded to the adhesive base layer 4a on the support 2 with the liner 3 and the pharmaceutical component support layer 5 thereon from the side of the pharmaceutical component support layer 5, and the support 2 and the pharmaceutical component as a whole.
  • the pressure-sensitive adhesive layer 4 and the liner 3 are laminated in this order, and the liner 3 is peeled off during use to make the pressure-sensitive adhesive layer 4 a plaster P1 that can be attached to the surface to be applied (skin surface).
  • the obtained plaster P1 is scraped off by a scraping roll 20.
  • the adhesive base layer 4a of the plaster P1 is formed in advance before containing a pharmaceutical ingredient, Thereafter, the adhesive base layer 4a is allowed to contain the pharmaceutical ingredient under a temperature condition that does not reduce the activity of the pharmaceutical ingredient. Therefore, the adhesive base layer 4a can be efficiently used without reducing the activity of the pharmaceutical ingredient. Can be contained (penetrated). Further, since the obtained plaster is penetrated from the side where the adhesive layer 4 is applied, the concentration distribution of the pharmaceutical component is large on the side where the adhesive is applied, so the effect of the pharmaceutical component is fast and large.
  • FIG. 3 is a schematic structural explanatory view showing Embodiment 2 of the plaster manufacturing apparatus according to the present invention
  • FIG. 4 is a schematic structural explanatory sectional view of the plaster.
  • the same components as those in Embodiment 1 are given the same numbers.
  • the plaster P2 includes a support 32, an adhesive layer 34 containing an active ingredient, and a liner 33, which are laminated in this order, and the liner 33 is peeled off during use to cover the adhesive layer 34. It is configured so that it can be attached to the application surface (skin surface) (for example, overall size: about 70 mm ⁇ about 100 mm).
  • the support 32 is made of a non-woven fabric made of polyester (support thickness: about 1 mm).
  • the liner 33 is made of a peelable synthetic sheet in which a sealing agent or a release agent is appropriately immersed in a synthetic paper (liner thickness: about 30 to 60 ⁇ m).
  • Adhesive layer 34 contains SIS-based adhesive as a hot-melt adhesive containing cell activation component ubidecaren (approximately 300 ⁇ g) as an active ingredient (adhesive layer thickness: approximately 100–200 xm). ).
  • the plaster manufacturing apparatus 31 includes a support transport means for transporting the support 32 from the support feed roll 6, a liner transport means for transporting the liner 33 from the liner feed roll 10, and a transport.
  • An adhesive base layer forming means for forming an adhesive base layer 34a on the support 32, a pharmaceutical ingredient applying means for applying a pharmaceutical ingredient solution on the formed adhesive base layer 34a, and a pharmaceutical ingredient are applied.
  • a liner 33 is bonded to the adhesive base layer 34a thus formed to form a plaster P2, and a plaster scraping unit for scraping the plaster P2 obtained by the bonding means.
  • the support conveying means and the adhesive base layer forming means are the same as in the first embodiment, and a description thereof will be omitted.
  • the liner conveying means includes a liner winding roll 10, which feeds out the liner 33 and guides and supplies it to a rubber roll 38 to be described later.
  • the medicinal component application means includes a container 15 for storing the medicinal component solution, and an adhesive base formed on the support 32 by the adhering base layer forming means by partially immersing the medicinal component solution in the container. It consists of a gravure roll 16 for applying a pharmaceutical component solution on the surface of the layer 34a, and a rubber roll 36 that comes into contact with this daravia roll. 23 is a gravure roll 16 scraper.
  • the laminating means is composed of a pair of rubber rollers 37 and 38 that are in contact with each other, and the liner 33 is pasted onto the adhesive base layer 34a coated with the pharmaceutical component solution.
  • the plaster scraping means comprises a scraping roll 20 that scrapes the plaster P2 by a torque motor (not shown).
  • Reference numeral 35 denotes a cooling chamber serving as a cooling section that allows a laminate in which the adhesive base layer 34a is formed on the support 32 to pass therethrough and lowers the temperature of at least the adhesive base layer 34a.
  • the support feeding roll 6 supplies the support 32 to the main roll 14 for forming the adhesive base layer with no tension via the no tension conveying roll 7 and the guide roll 8.
  • the first roll 9 and the second roll 12 are supplied with the SIS pressure-sensitive adhesive that has been heated to 160 to 180 ° C from the solid state to become molten, and the SIS pressure-sensitive adhesive in the molten state is 120 to 160 °. While adjusting the temperature to C, it is supplied onto the cooling roll 13 and spreads at a thickness of about 100 xm.
  • the cooling roller 13 forms an adhesive base layer 34a on the support 2 supplied to the main roller 14 while lowering the temperature of the spread SIS resin to about 45 ° C.
  • the gravure roll 16 applies the pharmaceutical component solution in the container 15 to the surface of the adhesive base layer 34a on the support 32.
  • a pair of rubber rollers 37 and 38 that are in contact with each other are bonded to a liner 33 on an adhesive base layer 34a coated with a pharmaceutical component solution, and as a whole, a support 32 and an adhesive layer 34 containing a pharmaceutical component
  • the liner 33 and the liner 33 are laminated in this order, and the liner 33 is peeled off during use, and the adhesive layer 34 is a plaster P2 that can be attached to the surface to be applied (skin surface).
  • the obtained blaster P2 is scraped off by a scraping roll 20.
  • the adhesive base layer 34a of this plaster P2 is formed in advance before containing the pharmaceutical ingredient, and then the adhesive base layer 34a is added with the pharmaceutical ingredient under a temperature condition that does not reduce the activity of the pharmaceutical ingredient.
  • the medicinal component can be contained (permeated / diffused) almost evenly and efficiently in the adhesive base layer 34a without reducing its activity.
  • the medicinal components permeate from the side where the adhesive layer 34 is applied as necessary, the concentration distribution of the medicinal components can be increased on the adhering side, so that the effect of the medicinal components is fast and large. The power to make S.

Abstract

An active ingredient is efficiently incorporated in or fixed to a pressure-sensitive adhesive layer without lowering the activity of the active ingredient. A process for producing a plaster comprising a substrate, a pressure-sensitive adhesive layer formed thereon which has an active ingredient incorporated therein or fixed thereto, and a liner superposed on the adhesive layer is provided. It comprises forming a pressure-sensitive base adhesive layer on a substrate or liner based on the melting of the pressure-sensitive adhesive itself or the evaporation of a solvent used while heating the pressure-sensitive adhesive according to the kind thereof, and incorporating or fixing the active ingredient to the pressure-sensitive base adhesive layer to continuously obtain a plaster, wherein the incorporation or fixation of the active ingredient to the pressure-sensitive base adhesive layer is conducted after the pressure-sensitive base adhesive layer which was heated in the formation thereof has been cooled to a temperature at which the activity of the active ingredient does not decrease.

Description

明 細 書  Specification
ブラスタ一の製造方法及びその製造装置及びプラスター用ライナー  Manufacturing method of blaster, manufacturing apparatus thereof, and liner for plaster
技術分野  Technical field
[0001] 本発明はプラスターの製造方法及びその製造装置に関し、さらに詳しくは、支持体 と、有効成分を含有または担持する粘着剤層と、ライナーとがこの順に積層され、使 用時にはライナーを剥離するプラスターを製造するプラスターの製造方法およびその 製造装置に関する。  TECHNICAL FIELD [0001] The present invention relates to a plaster manufacturing method and a manufacturing apparatus therefor, and more specifically, a support, a pressure-sensitive adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order. The present invention relates to a plaster manufacturing method and a manufacturing apparatus for manufacturing a plaster.
背景技術  Background art
[0002] プラスターは、医療用粘着テープ、絆創膏、貼付剤などとして知られているが、その 典型的な構成例は、支持体と、この一面に展延される粘着剤層と、この粘着剤層に 剥離可能に接着されるライナーとからなる。上記粘着剤の種類は、天然ゴム、合成ゴ ムとそれらの混合物、アクリル系ポリマーの溶液ゃェマルジヨン型、ホットメルト型およ び電子線硬化型が挙げられる。また上記粘着剤中に有効成分として医薬成分、化粧 成分等を含むプラスターを製造する場合、該有効成分を粘着剤中に混合して支持 体に塗布する方法が一般的である(例えば特許文献 1参照)。  [0002] Plaster is known as a medical pressure-sensitive adhesive tape, adhesive bandage, patch, and the like. Typical examples of the plaster include a support, a pressure-sensitive adhesive layer spread on one surface, and the pressure-sensitive adhesive. And a liner that is releasably adhered to the layer. Examples of the pressure-sensitive adhesive include natural rubber, synthetic rubber and a mixture thereof, an acrylic polymer solution emulsion type, a hot melt type, and an electron beam curable type. Further, when producing a plaster containing a pharmaceutical ingredient, a cosmetic ingredient, etc. as an active ingredient in the adhesive, a method of mixing the active ingredient in the adhesive and applying it to a support is common (for example, Patent Document 1). reference).
[0003] しかしながら、有効成分の多くは、有機溶剤系粘着剤の場合は塗工後の熱風(60 〜110°C程度)による溶剤除去 ·乾燥工程や、ホットメルト系粘着剤の場合は粘着基 剤への混入時にぉける加熱(170〜180°〇程度) ·混合工程において、有効成分の 揮散による減量や化学変化 ·分解等の熱劣化が引き起こされるという問題がある。 また、一方では織布ゃ不織布等の透過性支持体が用いられることが多いが、温度 が高ぐしたがって流動性の高い粘着剤を塗布すれば裏側に浸み出してしまうという 問題がある。  [0003] However, most of the active ingredients are organic solvent-based adhesives, solvent removal with hot air after coating (about 60-110 ° C) · drying process, and hot-melt adhesives are adhesive groups Heating at the time of mixing in the agent (about 170-180 ° ○) · There is a problem that in the mixing process, the active ingredient volatilizes and the chemical loss · thermal degradation such as decomposition occurs. On the other hand, a permeable support such as a woven fabric or a non-woven fabric is often used. However, since the temperature is high, there is a problem that if a highly fluid pressure-sensitive adhesive is applied, it oozes out to the back side.
特許文献 1 :特開平 8— 295624号公報  Patent Document 1: JP-A-8-295624
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] 本発明は、上記問題を解決することを課題としてなされたものであり、有効成分の 活性を低下させないで効率よく粘着剤層に含有または担持させることができると共に 、透過性支持体を用レ、ても粘着基剤の浸み出しを防止できるプラスターの製造方法 及びその製造装置を提供するものである。 [0004] The present invention has been made in order to solve the above-described problems, and can be efficiently contained or supported in an adhesive layer without reducing the activity of an active ingredient. Further, the present invention provides a method for producing a plaster and an apparatus for producing the same, which can prevent the seepage of the adhesive base even if a permeable support is used.
課題を解決するための手段  Means for solving the problem
[0005] 本発明の発明者らは、上記問題を解決すべく鋭意研究を重ね、有効成分を粘着基 剤層形成後でもその粘着基剤層に浸透により含有させることができるという知見を得 、この知見に基づき有効成分を含まない粘着基剤層をまず形成し、しかる後にこの粘 着基剤層を有効成分の活性を低下させない温度条件にした上で有効成分を含有さ せれば、上記問題を解決できることを見出し、本発明を完成するに至ったものである  [0005] The inventors of the present invention have made extensive studies to solve the above problems, and obtained the knowledge that the active ingredient can be contained in the adhesive base layer even after formation of the adhesive base layer. Based on this knowledge, an adhesive base layer that does not contain an active ingredient is first formed, and then the adhesive base layer is brought to a temperature condition that does not reduce the activity of the active ingredient and then the active ingredient is contained. Has been found to be able to solve the problem, and the present invention has been completed.
[0006] すなわち、本発明の 1つの特徴は、支持体と、有効成分を含有または担持する粘着 剤層と、ライナーとがこの順に積層されたプラスターを製造する方法であって、 支持体またはライナー上に粘着剤の種類に応じて加熱して粘着剤自体の溶融また は使用した溶剤の蒸発によって粘着基剤層を形成し、その粘着基剤層に該有効成 分を含有または担持させることによりプラスターを連続的に得ることよりなり、 [0006] That is, one feature of the present invention is a method for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order, the support or liner The adhesive base layer is formed by heating according to the type of the adhesive and melting the adhesive itself or evaporating the solvent used, and containing or carrying the effective component in the adhesive base layer. Consisting of continuously obtaining plaster,
粘着基剤層への有効成分の含有または担持が、粘着基剤層の形成時にした加熱 の温度を有効成分の活性を低下させない温度にまで降下させた状態で行われるプ ラスターの製造方法にある。 また、本発明の更なる特徴は、支持体またはライナー上に粘着基剤層を形成させ、 かつ粘着基剤層に有効成分を含有又は担持させるに際して粘着基剤層の加熱の温 度を有効成分の活性を低下させない温度条件にまで降下させるわけであるが、一方 的に粘着基剤層の温度を降下させるのではなぐその条件の内、より高い温度で粘 着基剤層に有効成分を含有または担持させ、それによつて (透過性の支持体への粘 着基剤層の浸み出しを防止できると共に、)有効成分を粘着基剤層に効果的に含有 または担持させ(高温での高い浸透性の利用)、ライナーと支持体のいずれ力 (特に ライナー)を、粘着基剤層を形成する過程でしっかり貼り合せできるようにし、さらにェ 業的な生産において温度を不必要に下げる無駄を省くと共に時間短縮を可能にし、 プラスターの品質と生産性を高めることにある。  In the method for producing a plaster, the active ingredient is contained or supported on the adhesive base layer in a state where the heating temperature at the time of forming the adhesive base layer is lowered to a temperature that does not reduce the activity of the active ingredient. . In addition, a further feature of the present invention is that when the adhesive base layer is formed on the support or liner, and the active ingredient is contained or supported on the adhesive base layer, the heating temperature of the adhesive base layer is determined as the active ingredient. However, it does not reduce the temperature of the adhesive base layer unilaterally, but the active ingredient is contained in the adhesive base layer at a higher temperature. Or by supporting (effectively preventing leaching of the adhesive base layer to the permeable support) and effectively containing or supporting the active ingredient in the adhesive base layer (high at high temperatures) The use of permeability) and the ability of the liner and support (especially the liner) to be firmly bonded in the process of forming the adhesive base layer, and the waste of lowering the temperature unnecessarily in industrial production. Save time and save time To, is to improve the quality and productivity of plaster.
ここで、粘着基剤層に含有または担持された有効成分の活性を低下させなレ、温度 は、有効成分にもよる力 例えば、約 130°C以下、好ましくは約 35〜約 100°C、さら に好ましくは、約 35〜約 80°Cである。なお、この有効成分の活性を低下させない温 度は、粘着基剤層の温度を検出する温度検出手段で得られる。特に限定されないが 、例えば、粘着基剤層表面の温度を検出する非接触型の赤外線サーモセンサで得 られる。 Here, the temperature of the active ingredient contained or supported in the adhesive base layer should not be lowered, the temperature Is a force depending on the active ingredient, for example, about 130 ° C or less, preferably about 35 to about 100 ° C, and more preferably about 35 to about 80 ° C. The temperature at which the activity of the active ingredient is not lowered can be obtained by temperature detecting means for detecting the temperature of the adhesive base layer. Although not particularly limited, for example, it can be obtained by a non-contact infrared thermosensor that detects the temperature of the surface of the adhesive base layer.
本発明において、粘着基剤層に有効成分を含有または担持させるとは、粘着基剤 層に有効成分を含有 (含浸または浸透)させるか、有効成分を完全に粘着基剤層の 表面上に担持させる場合と共に、粘着基剤層に有効成分の一部を含有させ、その残 りを粘着基剤層の表面に担持させる場合も含まれる。  In the present invention, the active ingredient is contained or supported in the adhesive base layer means that the active ingredient is contained (impregnated or penetrated) in the adhesive base layer, or the active ingredient is completely supported on the surface of the adhesive base layer. In addition to the above, the case where a part of the active ingredient is contained in the adhesive base layer and the rest is supported on the surface of the adhesive base layer is also included.
[0007] 本発明による有効成分を含有または担持する粘着剤層の形成は、(1)支持体上に 粘着基剤層を、ライナー上に有効成分を含有した有効成分含有層をそれぞれ形成 し、前記有効成分含有層を支持体上に形成された粘着基剤層の温度を所望の温度 に低下させた状態で貼り合わせることによるか、(2)支持体上に形成された粘着基剤 層の温度を所望の温度に低下させた状態で有効成分を溶解または分散した溶液を 前記粘着基剤層上に塗布することにより得られる。  [0007] Formation of the pressure-sensitive adhesive layer containing or carrying the active ingredient according to the present invention includes (1) forming an adhesive base layer on the support and forming an active ingredient-containing layer containing the active ingredient on the liner, The active ingredient-containing layer is bonded together in a state where the temperature of the adhesive base layer formed on the support is lowered to a desired temperature, or (2) of the adhesive base layer formed on the support It is obtained by applying a solution in which an active ingredient is dissolved or dispersed on the adhesive base layer in a state where the temperature is lowered to a desired temperature.
[0008] 本発明は、さらに別の観点によれば、支持体と、有効成分を含有または担持する粘 着剤層と、ライナーとがこの順に積層されたプラスターを製造する装置であって、支 持体を搬送する支持体搬送手段と、ライナーを搬送するライナー搬送手段と、搬送さ れる支持体とライナーのいずれか一方上に粘着基剤層を形成する粘着基剤層形成 手段と、搬送される支持体とライナーのいずれか他方上に有効成分含有層を形成す ることにより有効成分担持層を形成する有効成分担持層形成手段と、前記粘着基剤 層の温度を検知する温度検知手段と、この温度検知手段によって検知された温度が 有効成分の活性を低下させない温度にまで降下した状態で、前記粘着基剤層の表 面に前記有効成分担持層を貼り合わせ、有効成分を粘着基剤層に含有または担持 させる粘着基剤層と有効成分担持層との貼り合せ手段とを備えてなるプラスターの製 造装置を提供できる。  [0008] According to another aspect, the present invention provides an apparatus for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order. A support conveying means for conveying the carrier, a liner conveying means for conveying the liner, an adhesive base layer forming means for forming an adhesive base layer on one of the conveyed support and liner, and An active ingredient supporting layer forming means for forming an active ingredient supporting layer by forming an active ingredient containing layer on either the support or the liner, and a temperature detecting means for detecting the temperature of the adhesive base layer. In the state where the temperature detected by this temperature detecting means has been lowered to a temperature that does not decrease the activity of the active ingredient, the active ingredient carrying layer is bonded to the surface of the adhesive base layer, and the active ingredient is attached to the adhesive base. Contained in the layer Possible to provide a manufacturing apparatus of plaster comprising a bonding means to the adhesive base layer and the effective component carrying layer is to be carried.
[0009] 本発明は、さらに別の観点によれば、支持体と、有効成分を含有または担持する粘 着剤層と、ライナーとがこの順に積層されたプラスターを製造する装置であって、支 持体を搬送する支持体搬送手段と、ライナーを搬送するライナー搬送手段と、搬送さ れる支持体とライナーのいずれか一方上に粘着基剤層を形成する粘着基剤層形成 手段と、前記粘着基剤層の温度を検知する温度検知手段と、形成された粘着基剤 層上に、前記温度検知手段によって検知された温度が有効成分の活性を低下させ ない温度にまで降下した状態で、有効成分を溶解または分散した溶液を塗布し、有 効成分を粘着基剤層に含有または担持させる有効成分塗布手段と、 有効成分を含 有または担持した粘着基剤層上に支持体とライナーのいずれか他方を貼り合わせる 貝占り合せ手段とを備えてなるプラスターの製造装置を提供できる。 [0009] According to yet another aspect, the present invention is an apparatus for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order. A support transporting means for transporting the carrier; a liner transporting means for transporting the liner; an adhesive base layer forming means for forming an adhesive base layer on one of the transported support and liner; and the adhesive Effective when the temperature detected by the temperature detecting means detects the temperature of the base layer and the temperature detected by the temperature detecting means drops to a temperature at which the activity of the active ingredient does not decrease. Applying a solution in which an ingredient is dissolved or dispersed and applying or containing an active ingredient in or on an adhesive base layer, either a support or a liner on an adhesive base layer containing or carrying an active ingredient It is possible to provide a device for manufacturing a plaster comprising a shell-dividing means for attaching the other.
発明の効果  The invention's effect
[0010] 本発明によれば、支持体またはライナー上に粘着剤の種類に応じて溶融または溶 剤の蒸発によって粘着基剤層を予め形成し、しかる後にその粘着基剤層に有効成 分の活性を低下させない温度条件下で該有効成分を含有または担持させることによ つて、有効成分をその活性を低下させないで効率よく粘着剤層に含有させることがで きる。  [0010] According to the present invention, an adhesive base layer is formed in advance on the support or liner by melting or evaporating the solvent according to the type of the adhesive, and thereafter, an effective component is formed on the adhesive base layer. By containing or carrying the active ingredient under temperature conditions that do not reduce the activity, the active ingredient can be efficiently contained in the pressure-sensitive adhesive layer without reducing its activity.
さらに、本発明において、粘着基剤層に有効成分を含有又は担持させるに際して 粘着基剤層の加熱の温度を有効成分の活性を低下させない温度条件にまで降下さ せるわけであるが、一方的に粘着基剤層の温度を降下させるのではな その条件 の内、より高い温度で粘着基剤層に有効成分を含有または担持させ、それによつて 有効成分を粘着基剤層に効果的に含有または担持させ(高温での高い浸透性の利 用)、ライナーと支持体のいずれ力 ^特にライナー)を、粘着基剤層を形成する過程で しっかり貼り合せできるようにし、さらに工業的な生産において温度を不必要に下げる 無駄を省くと共に時間短縮を可能にし、プラスターの品質と生産性を高めることがで きる。  Furthermore, in the present invention, when the active ingredient is contained or supported in the adhesive base layer, the heating temperature of the adhesive base layer is lowered to a temperature condition that does not reduce the activity of the active ingredient. The temperature of the adhesive base layer is not lowered. Among those conditions, the active ingredient is contained or supported on the adhesive base layer at a higher temperature, thereby effectively containing the active ingredient in the adhesive base layer. Support (use high permeability at high temperature), and make sure that the liner and support force can be firmly bonded in the process of forming the adhesive base layer. Unnecessarily reducing waste and reducing time, and improving the quality and productivity of plasters.
図面の簡単な説明  Brief Description of Drawings
[0011] [図 1]本発明に係るプラスターの製造装置の実施の形態 1を示す概略構成説明図で ある。  FIG. 1 is a schematic configuration explanatory view showing a first embodiment of a plaster manufacturing apparatus according to the present invention.
[図 2]図 1の実施の形態 1で製造されるプラスターの概略構成説明断面図である。  2 is a cross-sectional view illustrating a schematic configuration of the plaster manufactured in Embodiment 1 of FIG.
[図 3]本発明に係るプラスターの製造装置の実施の形態 2を示す概略構成説明図で ある。 FIG. 3 is a schematic configuration explanatory view showing Embodiment 2 of a plaster manufacturing apparatus according to the present invention. is there.
園 4]図 3の実施の形態 2で製造されるプラスターの概略構成説明断面図である。 符号の説明 4] FIG. 4 is a cross-sectional view illustrating the schematic configuration of the plaster manufactured in the second embodiment shown in FIG. Explanation of symbols
1 プラスターの製造装置  1 Plaster production equipment
2 支持体  2 Support
3 ライナー  3 liner
4 粘着剤層  4 Adhesive layer
4a 粘着基剤層  4a Adhesive base layer
5 医薬成分担持層  5 Pharmaceutical component carrier layer
6 支持体繰出しロール  6 Support roll
7 供給ロール  7 Supply roll
8 ガイドロール  8 Guide roll
9 第 1ロール  9 First roll
10 ライナー繰出しロール  10 Liner feed roll
11 ガイドロール  11 Guide roll
12 第 2ロール  12 Second roll
13 冷却ロール  13 Cooling roll
14 主ロール  14 Main roll
15 容器  15 containers
16 グラビアローノレ  16 Gravure Ronole
17 ゴムロール  17 Rubber roll
18 副ロール  18 Secondary roll
19 ンマローノレ  19 Nmalone
20 プラスター卷取りロール  20 Plaster culling roll
21 ガイドロール  21 Guide roll
22 ガイドロール  22 Guide roll
23 ドクターブレード  23 Doctor blade
PI プラスター 発明を実施するための最良の形態 PI plaster BEST MODE FOR CARRYING OUT THE INVENTION
[0013] 本発明に係るプラスターの製造方法は、支持体と、有効成分を含有または担持す る粘着剤層と、ライナーとがこの順に積層され、使用時にライナーを剥離して粘着剤 層側から被貼付面に貼り付けるプラスターを製造対象としている。  [0013] In the method for producing a plaster according to the present invention, a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order, and the liner is peeled off during use from the adhesive layer side. The plaster to be attached to the surface to be applied is the manufacturing target.
[0014] 本発明においては、支持体またはライナー上にまず粘着基剤層(有効成分を含ま ない粘着剤の層を意味する)を形成し、その粘着基剤層に有効成分の活性を低下さ せない温度条件下で該有効成分を含有または担持させる。  In the present invention, an adhesive base layer (meaning an adhesive layer not containing an active ingredient) is first formed on a support or liner, and the activity of the active ingredient is reduced in the adhesive base layer. The active ingredient is contained or supported under temperature conditions that do not.
ここで、支持体の材質および形状は、当該分野で知られたものが使用できる。より 具体的に言えば、プラスターの製造原料としては、シートまたはフィルム状のものが 用いられ、プラスターの形成後に適当なサイズにカットされる。その材質は、天然繊維 、合成樹脂繊維からなる不織布や織布、その他合成樹脂フィルムなどいずれでもよく 、例えばポリエステル、ポリプロピレンまたはレーヨンなどの繊維の一種または複数種 を用いて布状に成形された不織布、ポリエステル繊維からなる織布、スフを用いて織 られた布であるスフモスリン、塩化ビュルフィルム、ポリエチレンフィルム、ポリウレタン •塩ビ共重合体フィルム、ポリウレタンフィルムなどが好ましいものとして挙げられる。 その他、セロハン、酢酸セルローズ、ポリ塩化ビニリデン、二トリルゴム、ポリプロピレン のホモまたはコポリマー、ポリアミド、ポリテトラフルォロエチレンなどの合成樹脂や、 他のポリマーとのブレンドなども好ましい材質として挙げることができる力 S、別段これら に限定されるものではなぐ支持体は用途によって選ばれる。  Here, as the material and shape of the support, those known in the art can be used. More specifically, as the raw material for producing the plaster, a sheet or a film is used, which is cut into an appropriate size after the plaster is formed. The material may be any of non-woven fabrics and woven fabrics made of natural fibers, synthetic resin fibers, and other synthetic resin films. For example, non-woven fabrics formed into a cloth using one or more types of fibers such as polyester, polypropylene, or rayon. Preferable examples include woven fabric made of polyester fiber, sufumuslin, a chlorinated bure film, a polyethylene film, a polyurethane / vinyl chloride copolymer film, and a polyurethane film that are woven using soot. In addition, cellophane, cellulose acetate, polyvinylidene chloride, nitrile rubber, polypropylene homo or copolymer, polyamide, polytetrafluoroethylene, and other synthetic resins, and blends with other polymers can also be listed as preferred materials. S, a support that is not limited to these, is selected depending on the application.
[0015] ライナーとしては、剥離性を持った両面を加工した紙、フィルム、さらにクレープ紙、 あるいはエンボス状のフィルム、また他の剥離剤を塗工したフィルムなどである。フィ ルムとしては、塩化ビニルフィルム、ポリエチレンフィルム、ポリプロピレンフィルム、ポ リエステルフィルム、ポリエチレンテレフタレートフィルムなどが挙げられる。上記フィ ルムにシリコーン処理したシリコーン剥離ライナーは特に重要である。  [0015] Examples of the liner include paper and films processed on both sides having releasability, crepe paper, embossed films, and films coated with other release agents. Examples of the film include a vinyl chloride film, a polyethylene film, a polypropylene film, a polyester film, and a polyethylene terephthalate film. Of particular importance are silicone release liners wherein the film is silicone treated.
[0016] 粘着基剤層を形成する粘着剤としては、天然ゴム、合成ゴムとそれらの混合物、ァ クリル系ポリマーの溶液ゃェマルジヨン型、ホットメルト型および電子線硬化型を挙げ ることができる(日刊工業新聞社発行「粘着技術ノ、ンドブック」 P774〜775参照)。 これらの粘着剤は、その種類によって粘着基剤層を形成する方法を異にしているが 、いずれの方法でも高温を経て粘着基剤層を形成するに至るので、本発明において は、粘着基剤層が有効成分の活性を低下させない温度条件下になレ、(温度が高い) 場合は、有効成分の活性を低下させない温度条件に調整した上で有効成分を含有 または担持させる。 [0016] Examples of the pressure-sensitive adhesive forming the pressure-sensitive adhesive base layer include natural rubber, synthetic rubber and a mixture thereof, a solution-based emulsion type of acrylic polymer, a hot melt type, and an electron beam curable type ( Published by Nikkan Kogyo Shimbun, “Adhesion Technology No. Book” pages 774-775). These pressure-sensitive adhesives have different methods for forming a pressure-sensitive adhesive base layer depending on their types. In any of these methods, the adhesive base layer is formed through a high temperature. Therefore, in the present invention, when the adhesive base layer does not decrease the activity of the active ingredient, (when the temperature is high) The active ingredient is contained or supported after adjusting to a temperature condition that does not reduce the activity of the active ingredient.
そして、このような温度条件下で粘着基剤層に有効成分を含有または担持させるに 当たっては、有効成分の粘着基剤層への浸透を効果的にすることや、他方のライナ 一または支持体との貼り付けを十分行うことなどを考慮して、粘着剤の種類ごとに以 下のごとき方法を採用するのが望ましい。  When the active ingredient is contained or supported on the adhesive base layer under such temperature conditions, the penetration of the active ingredient into the adhesive base layer can be made effective, or the other liner can be supported or supported. In consideration of sufficient adhesion to the body, it is desirable to adopt the following method for each type of adhesive.
[0017] (1)ホットメルト型の粘着剤  [0017] (1) Hot melt adhesive
ホットメルト型の粘着剤では、高温 (例えば 120〜180°C)に加熱して溶融させ、展 延または塗布 (塗工)により、支持体とライナーのいずれか一方上に粘着基剤層を形 成する。そしてこの粘着基剤層に有効成分の活性を低下させなレ、温度条件下で該 有効成分を含有または担持させるわけであるが、有効成分の活性を低下させない温 度条件の内、より高い温度条件で粘着基剤層に有効成分を含有させ、それによつて 有効成分を粘着基剤層に効果的に浸透させ(高温での高い浸透性の利用)、支持 体とライナーのいずれか他方(特にライナー)をしつかり貼り合せできるようにし (高温 での高い粘着性の利用)、さらに特に工業的な生産において、温度を不必要に下げ る無駄を省くことができる。  Hot-melt adhesives are heated to a high temperature (for example, 120 to 180 ° C) and melted, and an adhesive base layer is formed on either the support or liner by spreading or coating (coating). To do. The adhesive base layer contains or carries the active ingredient under temperature conditions that do not reduce the activity of the active ingredient, but the temperature is higher than the temperature conditions that do not reduce the activity of the active ingredient. The active ingredient is contained in the adhesive base layer under certain conditions, whereby the active ingredient is effectively infiltrated into the adhesive base layer (use of high permeability at high temperature), and either the support or the liner (especially (Liner) can be tightly bonded (use of high tack at high temperatures), and in particular, in industrial production, unnecessary waste of temperature reduction can be eliminated.
[0018] ここで、ホットメルト型のゴム系粘着剤としては、下記エラストマ一と粘着付与剤との 組み合わせが挙げられる。すなわち、エラストマ一としては、天然ゴム、合成ポリイソ プレンゴム、スチレン.ブタジエンゴム、スチレン.イソプレンブロック共重合体、ポリイソ ブチレン、ブチルゴム、スチレン一イソプレン一スチレンブロック共重合体(省略して S ISと称す。以下同様)、スチレンブタジエンゴム(SBR)、スチレンブタジエンゴムの水 素添加物(SBRS)等が挙げられる。  [0018] Here, examples of the hot-melt rubber-based pressure-sensitive adhesive include a combination of the following elastomer and a tackifier. That is, as an elastomer, natural rubber, synthetic polyisoprene rubber, styrene-butadiene rubber, styrene-isoprene block copolymer, polyisobutylene, butyl rubber, styrene-isoprene-styrene block copolymer (abbreviated as SIS). The same applies hereinafter), styrene butadiene rubber (SBR), hydrogen additive of styrene butadiene rubber (SBRS), and the like.
[0019] また、粘着付与剤としては、ロジン、水添ロジン、ロジンエステル、水添ロジンエステ ノレ、ポリテノレペン、テルペンフエノール、フエノール樹脂、キシレン樹脂、クマロンイン デン樹脂、その他脂肪族系樹脂 (C5系樹脂)、石油系樹脂、脂環式炭化水素樹脂( 水添芳香族系樹脂)等が挙げられる。 [0020] これらエラストマ一と粘着付与剤とを組み合わせたゴム系粘着剤は、常温で固形の ブロック体とすることができ、それを高温 (例えば 120〜180°C)に加熱することによつ て溶融させ、支持体またはライナー上に直接展延 (塗工)して粘着基剤層を形成する 、別途ロールなどの上に展延(塗工)して粘着基剤層を形成し、し力る後に支持体 とライナーのレ、ずれか一方上に該粘着基剤層を貼り付け (転写し)てもよレ、。 [0019] Tackifiers include rosin, hydrogenated rosin, rosin ester, hydrogenated rosin ester, polytenolene, terpene phenol, phenol resin, xylene resin, coumarone indene resin, and other aliphatic resins (C5 resin). , Petroleum resins, alicyclic hydrocarbon resins (hydrogenated aromatic resins), and the like. [0020] A rubber-based pressure-sensitive adhesive in which these elastomers and a tackifier are combined can be made into a solid block at room temperature, and heated by heating to a high temperature (for example, 120 to 180 ° C). And then spread (apply) directly on the support or liner to form an adhesive base layer. Separately spread (apply) on a roll or the like to form an adhesive base layer. After pressing, the adhesive base layer may be attached (transferred) on the support or liner.
なお、粘着剤層の厚みは、プラスターの粘着力と有効成分の保持力との確保を考 慮して一般的に 10〜: 1000 z m、好ましくは 20〜200 z mに設定される。  The thickness of the pressure-sensitive adhesive layer is generally set to 10 to 1000 zm, preferably 20 to 200 zm in consideration of securing the adhesive strength of the plaster and the retention strength of the active ingredient.
[0021] (2)溶剤型の粘着剤  [0021] (2) Solvent-type adhesive
溶剤型の粘着剤では、粘着剤を溶剤に溶力して展延または塗布(塗工)し、次いで 高温 (例えば 120°C)下で溶剤を蒸発させて支持体とライナーのいずれか一方上に 粘着基剤層を形成する。そしてこの粘着基剤層に有効成分の活性を低下させない 温度条件下で該有効成分を含有または担持させるわけであるが、有効成分の活性を 低下させない温度条件の内、より高い温度条件で、しかも溶剤を完全に蒸発させる 前に、粘着基剤層に有効成分を含有または担持させ、それによつて有効成分を粘着 基剤層に効果的に浸透させ(高温での高い浸透性の利用)、支持体とライナーのい ずれか他方(特にライナー)を、粘着基剤層を形成する過程でしっかり貼り合せできる ようにし、さらに特に工業的な生産において、温度を不必要に下げる無駄を省くこと ができる。  With solvent-type adhesives, the adhesive is spread or applied (coating) by dissolving it in a solvent, and then the solvent is evaporated at a high temperature (for example, 120 ° C) to either the support or the liner. An adhesive base layer is formed. The adhesive base layer contains or carries the active ingredient under a temperature condition that does not reduce the activity of the active ingredient, but the temperature condition does not reduce the activity of the active ingredient at a higher temperature condition. Before the solvent is completely evaporated, the active ingredient is contained or supported on the adhesive base layer, so that the active ingredient can effectively penetrate into the adhesive base layer (use of high permeability at high temperature) and support It is possible to firmly attach either the body or the liner (especially the liner) in the process of forming the adhesive base layer, and it is possible to eliminate the waste of lowering the temperature unnecessarily, especially in industrial production. .
[0022] ここで、溶剤型のアクリル系粘着剤としては、下記主モノマーと副モノマーとの組み 合わせが挙げられる。すなわち、主モノマーとしては、アクリル酸ェチル、アクリル酸 ブチル、アクリル酸 2—ェチルへキシル、アクリル酸ォクチル、アクリル酸イソォクチル 、アクリル酸デシル、メタアクリル酸デシル、アクリル酸ドデシル、メタアクリル酸ドデシ ル等が挙げられる。また、副モノマーとしては、アクリル酸、酢酸ビュル、アクリル酸メ チル、メタアクリル酸メチル、無水マレイン酸、アクリル酸 2—ヒドロキシェチル等が挙 げられる。  Here, examples of the solvent-type acrylic pressure-sensitive adhesive include combinations of the following main monomers and submonomers. That is, as the main monomer, ethyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, octyl acrylate, isooctyl acrylate, decyl acrylate, decyl methacrylate, dodecyl acrylate, dodecyl methacrylate, etc. Is mentioned. In addition, examples of the secondary monomer include acrylic acid, butyl acetate, methyl acrylate, methyl methacrylate, maleic anhydride, and 2-hydroxyethyl acrylate.
[0023] これら主モノマーと副モノマーとを組み合わせるアクリル系粘着剤は、適宜添加剤 を加え特定の溶剤に溶かして支持体またはライナー上に塗布(展延または塗工)し、 次いで高温 (例えば 120°C)の乾燥トンネルに通して適宜溶剤を蒸発させて粘着基 剤層を形成する。 [0023] The acrylic pressure-sensitive adhesive combining the main monomer and the submonomer is appropriately added with an additive, dissolved in a specific solvent, coated (spread or coated) on a support or liner, and then heated (for example, 120). ° C) through a drying tunnel to properly evaporate the solvent and An agent layer is formed.
[0024] 上記粘着基剤層には、適宜、軟化剤(可塑剤)、吸収促進剤、多価アルコール類、 シリコーン油類、無機充填剤、酸化防止剤 (紫外線吸収剤)等が用いられる。特に有 効成分を、これを溶解または分散させ、かつ粘着基剤層に浸透しうる低分子化合物 の軟化剤(可塑剤)と共に用いるのが好ましレ、。  [0024] A softener (plasticizer), an absorption accelerator, polyhydric alcohols, silicone oils, inorganic fillers, antioxidants (ultraviolet absorbers) and the like are appropriately used for the adhesive base layer. In particular, it is preferable to use an active ingredient together with a softening agent (plasticizer) of a low molecular compound that can dissolve or disperse the active ingredient and penetrate into the adhesive base layer.
[0025] 上記軟化剤(可塑剤)としては、ポリブテン、ポリイソブチレン、ジォクチルフタレート 、ジブチルフタレート、ジェチルフタレート、液状ロジンエステル、塩素化パラフィン、 プロセスオイル、ラノリン、 IPM、シリコーン、ワセリン、固形パラフィン、流動パラフィン 、プラスティペース、ミツロウ、メントーノレ、リモネン、ビネン、ピペリトン、テルピノール、 カルべオール、アーモンド油、ォリーブ油、ツバキ油、パーシック油、ハツ力油、ゴマ 油、ダイズ油、ミンク油、綿実油、トウモロコシ油、サフラワー油、ブドウ油、マカデミア ナッツ油、卵黄油、紅花油、クロタミトン、ピロリドン、液状ポリイソプレン、中鎖脂肪酸 トリグリセリド、ポリエチレングリコール、ベンジルアルコール、ォレイルアルコール、ジ メチルアミド、アジピン酸ジイソプロピル、リノレン酸、力プリン酸、ォレイン酸、ステアリ ン酸、マリスチン酸、リノール酸、ォレフィン酸、プロピレングリコール、ブチレングリコ ール、スクヮラン、スクワレン、ユーカリ油、パーム油、ヤシ油、ラッカセィ油、炭酸プロ ピレン、ジォクチルフタレート、ジブチルフタレート、ラウリルアルコール、トリイソプロパ ノーノレアミン、ジイソプロパノールァミン、モノォレイン酸ポリオキシエチレンソルビタン 等が挙げられる。これらは、有効成分に応じて単独で又は複数種混合して用いられ る。  [0025] Examples of the softener (plasticizer) include polybutene, polyisobutylene, dioctyl phthalate, dibutyl phthalate, jetyl phthalate, liquid rosin ester, chlorinated paraffin, process oil, lanolin, IPM, silicone, petrolatum, solid Paraffin, liquid paraffin, plastic pace, beeswax, mentholenole, limonene, binene, piperiton, terpinol, carveol, almond oil, olive oil, camellia oil, persic oil, hearth oil, sesame oil, soybean oil, mink oil, Cottonseed oil, corn oil, safflower oil, grape oil, macadamia nut oil, egg yolk oil, safflower oil, crotamiton, pyrrolidone, liquid polyisoprene, medium chain fatty acid triglyceride, polyethylene glycol, benzyl alcohol, oleyl alcohol, dimethyl alcohol Tyramide, diisopropyl adipate, linolenic acid, force puric acid, oleic acid, stearic acid, maristynic acid, linoleic acid, olephinic acid, propylene glycol, butylene glycol, squalene, squalene, eucalyptus oil, palm oil, coconut oil, Examples include laccase oil, propylene carbonate, dioctyl phthalate, dibutyl phthalate, lauryl alcohol, triisopropanolanolamine, diisopropanolamine, and polyoxyethylene sorbitan monooleate. These may be used alone or in combination of two or more depending on the active ingredient.
[0026] 上記多価アルコールとしては、グリセリン、プロピレングリコール、オクタンジオール、 ポリエチレングリコール、 D—ソルビット、クロタミトン等が挙げられる。  [0026] Examples of the polyhydric alcohol include glycerin, propylene glycol, octanediol, polyethylene glycol, D-sorbit, crotamiton and the like.
上記シリコーン油としては、メチルシロキサン、メチルフエ二ルポリシロキサン、ドデカ メチルポリシロキサン等が挙げられる。  Examples of the silicone oil include methylsiloxane, methylphenylpolysiloxane, dodecamethylpolysiloxane, and the like.
上記無機充填剤としては、酸化亜鉛、酸化チタン、炭酸カルシウム等が挙げられる 上記酸化防止剤(紫外線吸収剤)としては、 BHT、 DTBHQ等が挙げられる。  Examples of the inorganic filler include zinc oxide, titanium oxide, and calcium carbonate. Examples of the antioxidant (ultraviolet absorber) include BHT and DTBHQ.
[0027] 本発明に係るプラスターの粘着基剤層に含有または担持させるのに適した有効成 分としては、次のごとき医薬成分(医薬品)、化粧成分 (化粧品)、香料が挙げられる。 医薬成分(医薬品)としては消炎鎮痛剤、ホルモン剤、局所麻酔剤、心疾患硝酸剤 、動揺病治療剤、更年期障害治療剤、高血圧治療剤、癌性疼痛緩和剤、気管支拡 張剤、禁煙補助剤、頻尿'尿失禁治療剤等が挙げられ、具体的なものとして、フェル ピナク、インドメタシン、ケトプロフェン、フルルビプロフェン、サリチル酸メチル、サリチ ル酸グリコール、メントーノレ、吉草酸ベタメタゾン、インシュリン、リドカイン(MT66〜6 9°C、 BT159〜: 160°C)、硝酸イソソルビド、ニトログリセリン(50。C以下で安定)、スコ ポラミン、エストラジオール、クロ二ジン、フェンタニル、クェン酸フェンタニル、ッロブ テロール、ニコチン、塩酸ォキシブチニン、ジクロフェナクナトリウム、塩酸エペリゾン、 ロキソプロフェンナトリウム、カプサイシン(ΜΤ65· 7〜66. 3°C)、塩酸トラニゾール、 ケトロラタ、スプロフェン、ザルトプロフェン、塩酸ジブ力イン、テストステロン、ピロキシ カム、サリチル酸、プロゲステロン、カンフル、エダラボン、バルデコキシブ、セレコキ シブ、口フエコキシブ、エストロゲン、プロゲストゲン、クロ二ジン、テオフィリン、ノニル 酸ヮニリルアミド、トウガラシエキス、アスピリン、硫酸サルブタモール、塩酸イソプロテ ノール、ァリルエストレノール、ハイド口コルチゾン、プレドニゾロン、メチルプレゾ二ドロ ン、トリアムシノロン、デキサメタゾン、パラメタゾン並びにこれらコルチゾンの誘導体及 び塩類などを挙げることができる力 これらに限定されるものではない。 [0027] Effective composition suitable for inclusion or support in the adhesive base layer of the plaster according to the present invention. Examples of the ingredients include the following pharmaceutical ingredients (pharmaceuticals), cosmetic ingredients (cosmetics), and fragrances. Pharmaceutical components (pharmaceuticals) include anti-inflammatory analgesics, hormonal agents, local anesthetics, nitrates for heart disease, therapeutic agents for motion sickness, therapeutic agents for menopause, antihypertensive agents, cancer pain relieving agents, bronchodilators, smoking cessation aids , Urinary incontinence treatment, etc., and specific examples include ferpinac, indomethacin, ketoprofen, flurbiprofen, methyl salicylate, glycol salicylate, mentholore, betamethasone valerate, insulin, lidocaine ( MT66 ~ 6 9 ° C, BT159 ~: 160 ° C), isosorbide nitrate, nitroglycerin (stable at 50 ° C or less), scopolamine, estradiol, clonidine, fentanyl, fentanyl citrate, lobbuterol, nicotine, hydrochloric acid Oxybutynin, diclofenac sodium, eperisone hydrochloride, loxoprofen sodium, cap Isin (ΜΤ 65.7-66.3 ° C), tranisol hydrochloride, ketorolata, suprofen, zaltoprofen, dibu force in, testosterone, piroxicam, salicylic acid, progesterone, camphor, edaravone, valdecoxib, celecoxib, oral fuecoxib, estrogen, Progestogen, Clondin, Theophylline, Nonyl oxynitrylamide, Pepper extract, Aspirin, Salbutamol sulfate, Isoprotenol hydrochloride, Arylestrenol, Hyde mouth cortisone, Prednisolone, Methylprezidolone, Triamcinolone, Dexamethasone, Parameterzone and these cortisones Powers that can include derivatives and salts of these are not limited to these.
[0028] また、化粧成分 (化粧品)としては、ビタミン類、保湿剤、美白剤、血行促進成分、抗 酸化成分、細胞賦活成分、抗アレルギー成分などを挙げることができ、具体的には、 ビタミン C、ビタミン E、アルブチン、ュビデカレノンなどを挙げることができるがこれら に限定されるものではない。なお、有効成分の活性を低下させない温度は、例えば、 細胞賦活成分のュビデカレンでは 45°C以下である。  [0028] In addition, examples of cosmetic ingredients (cosmetics) include vitamins, moisturizers, whitening agents, blood circulation promoting ingredients, antioxidant ingredients, cell activation ingredients, antiallergic ingredients, and the like. Examples include, but are not limited to, C, vitamin E, arbutin, and ubidecarenone. The temperature at which the activity of the active ingredient is not reduced is, for example, 45 ° C. or less for the cell activation ingredient ubidecaren.
香料としては、スイートオレンジ、レモン、ベルガモット、ペパーミント、ラベンダー、 ゼラニゥム、ローズ、ジャスミン、バジル、ユーカリ等を挙げることができる力 これらに 限定されるものではない。  Examples of the fragrance include sweet orange, lemon, bergamot, peppermint, lavender, geranium, rose, jasmine, basil, eucalyptus, and the like, but are not limited to these.
[0029] 上記のような有効成分を塗布する際は、有効成分を適当な媒体に溶解または分散 した溶液で使用される。媒体は、主に有効成分の種類による有機溶剤や水に対する 溶解性のような物理的性質を考慮して選択されるが、その上、粘着基剤層と親和性 または相溶性を有する媒体の使用が、有効成分を粘着基剤層に高濃度に含有また は浸透させるのに好ましい。当業者であれば、媒体の選択は、特別な実験を必要と することなく容易になし得ることである。 [0029] When the active ingredient as described above is applied, it is used in a solution in which the active ingredient is dissolved or dispersed in an appropriate medium. The medium is selected mainly considering the physical properties such as solubility in organic solvents and water depending on the type of active ingredient, but in addition, it is compatible with the adhesive base layer. Alternatively, the use of a compatible medium is preferable for containing or penetrating the active ingredient in the adhesive base layer at a high concentration. A person skilled in the art can easily select the medium without the need for special experimentation.
上記媒体としては、前記した軟ィヒ剤(可塑剤)を有効成分に応じて単独で又は複数 種混合して使用することが出来る。たとえば、クロタミトンは、ケトプロフェン、イブプロ フェン、リドカイン、フルルビプロフェン、アスピリン、フェルビナクなどの医薬成分に対 して好適に用いられ、ピロリドンは、ケトプロフェン、イブプロフェン、リドカイン、フェル ピナク、ジクロフヱナクナトリウムなどの医薬成分に対して好適に用いられ、イソプロパ ノールアミンは、ケトプロフェン、イブプロフェン、リドカイン、フルルビプロフェン、ァス ピリンなどの医薬成分に対して好適に用いられ、ハツ力油は、ケトプロフェン、イブプ 口フェン、リドカイン、フルルビプロフェンなどの医薬成分に対して好適に用いられる。 しかしながらこれらに限定されるものではない。  As the above medium, the above-mentioned softeners (plasticizers) can be used singly or in combination according to the active ingredient. For example, crotamiton is preferably used for pharmaceutical ingredients such as ketoprofen, ibuprofen, lidocaine, flurbiprofen, aspirin, felbinac, and pyrrolidone is used for ketoprofen, ibuprofen, lidocaine, felpinac, diclofenac sodium Isopropanolamine is preferably used for pharmaceutical ingredients such as ketoprofen, ibuprofen, lidocaine, flurbiprofen, and aspirin. It is preferably used for pharmaceutical ingredients such as oral fen, lidocaine, flurbiprofen and the like. However, it is not limited to these.
また、粘着基剤層との貼り合わせに使用する有効成分含有層は、有効成分を適当 な液状または固体の担体 (必要に応じて溶剤を添加)に均一にかつ適当な濃度に支 持させて形成させる。液状または固体の担体は、有効成分に対し不活性でかつ粘着 基剤層との貼り合わせ後に容易に除去できるか、実質的に残存しないものが好ましく 、これも、前記した軟化剤(可塑剤)を有効成分に応じて単独でまたは複数種混合し て使用できる。  In addition, the active ingredient-containing layer used for bonding with the adhesive base layer allows the active ingredient to be supported uniformly and at an appropriate concentration on an appropriate liquid or solid carrier (a solvent is added if necessary). Let it form. The liquid or solid carrier is preferably one that is inert to the active ingredient and can be easily removed after bonding with the adhesive base layer or does not substantially remain. This is also the softener (plasticizer) described above. Can be used alone or as a mixture of two or more thereof depending on the active ingredient.
次に、粘着基剤層の温度を具体的に上述の医薬成分や化粧成分の活性を低下 させない温度にするには、次の温度調節手段を適宜採用できる。  Next, in order to set the temperature of the adhesive base layer to a temperature that does not specifically reduce the activity of the above-described pharmaceutical ingredients and cosmetic ingredients, the following temperature adjusting means can be appropriately employed.
(1)粘着基剤層を有効成分の活性を低下させない温度に調整する温度調整手段、 例えば粘着基剤層を形成する口一ラを設ける。  (1) A temperature adjusting means for adjusting the adhesive base layer to a temperature that does not reduce the activity of the active ingredient, for example, a mouthpiece for forming the adhesive base layer.
(2)粘着基剤層形成手段を、供給される高温の粘着剤をロール面上に展延して粘 着基剤層とする粘着基剤層形成ロールと、搬送される支持体とライナーのいずれか 一方上に前記粘着基剤層を貼り合せる貼り合せロールとで構成し、この貼り合せロー ルに、前記粘着基剤層の温度を有効成分の活性を低下させない温度に下げる冷却 器を熱交換的に設ける。  (2) Adhesive base layer forming means comprising: an adhesive base layer forming roll in which the supplied high-temperature adhesive is spread on the roll surface to form an adhesive base layer; It is composed of a laminating roll for laminating the pressure-sensitive adhesive base layer on either one, and a cooler for lowering the temperature of the pressure-sensitive adhesive base layer to a temperature that does not decrease the activity of the active ingredient is heated on this laminating roll. Provide interchangeably.
(3)搬送される支持体とライナーのレ、ずれか一方とその上に形成された粘着基剤 層とを通過させることにより少なくとも粘着基剤層の温度を有効成分の活性を低下さ せない温度に下げる冷却室を設ける。 (3) One of the support and liner to be conveyed, one of them, and the adhesive base formed thereon A cooling chamber is provided by passing through the layer to lower at least the temperature of the adhesive base layer to a temperature that does not decrease the activity of the active ingredient.
もちろん、粘着基剤層の温度が医薬成分や化粧成分の活性を低下させない温度 に自然になつている場合は、温度調節手段は不要である。  Of course, if the temperature of the adhesive base layer is naturally at a temperature that does not decrease the activity of the pharmaceutical ingredient or cosmetic ingredient, the temperature adjusting means is unnecessary.
[0031] そして、予め形成した粘着基剤層に有効成分を含有させるには、具体的には、支 持体上に粘着基剤層を、ライナー上に有効成分含有層をそれぞれ形成し、支持体 上に形成された粘着基剤層に有効成分含有層を貼り合わせる。ライナー上に粘着基 剤層を形成し、支持体上に有効成分含有層をそれぞれ形成し、ライナー上に形成さ れた粘着基剤層に有効成分含有層を貼り合わせてもよレ、。 [0031] And, in order to contain the active ingredient in the preformed adhesive base layer, specifically, the adhesive base layer is formed on the support and the active ingredient-containing layer is formed on the liner, respectively. The active ingredient-containing layer is bonded to the adhesive base layer formed on the body. An adhesive base layer may be formed on the liner, an active ingredient-containing layer may be formed on the support, and the active ingredient-containing layer may be bonded to the adhesive base layer formed on the liner.
[0032] また、支持体またはライナー上に粘着基剤層を形成し、この粘着基剤層上に有効 成分を溶解または分散した溶液を展延または塗布(塗工)してもよレ、。塗布はロール 方式、スプレー方式などが挙げられる。 [0032] Alternatively, an adhesive base layer may be formed on a support or liner, and a solution in which an active ingredient is dissolved or dispersed may be spread or applied (coated) on the adhesive base layer. Examples of the application include roll method and spray method.
本発明においては、もちろん、上述の貼り合せまたは塗布によって粘着基剤層に浸 透 (移行または含浸)させ、含有または担持させることができる有効成分が選択して使 用される。  In the present invention, as a matter of course, an active ingredient that can permeate (transfer or impregnate) the adhesive base layer by the above-mentioned bonding or coating, and can be contained or supported is selected and used.
貼り合せ又は塗布により粘着基剤層に接触させられた有効成分担持層から有効成 分が粘着基剤層中に浸透'拡散し、有効成分がほぼ均等に含有された粘着剤層が 形成される。たとえば 50〜200 μ mの粘着基剤層に対して塗布又は貼り合わされた 有効成分:!〜 2週間で粘着基剤層中に均一に拡散 ·浸透する。  The active ingredient permeates and diffuses into the adhesive base layer from the active ingredient carrying layer brought into contact with the adhesive base layer by bonding or coating, thereby forming an adhesive layer containing the active ingredient almost evenly. . For example, active ingredients applied or bonded to a 50 to 200 μm adhesive base layer:! To diffuse and penetrate uniformly into the adhesive base layer in 2 weeks.
本発明において、得られるプラスターは、支持体と、有効成分を含有または担持す る粘着剤層と、ライナーとがこの順に積層された構成であって、使用時にはライナー を剥離し、プラスターをその剥離された面側 (粘着剤層)から所望の皮膚面に貼付さ れるわけである。また、必要に応じて粘着基剤層の有効成分の濃度分布を、ライナー 佃 Jで大きくすることもできる。  In the present invention, the obtained plaster has a structure in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order. The liner is peeled off during use, and the plaster is peeled off. It is applied to the desired skin surface from the coated surface side (adhesive layer). Further, if necessary, the concentration distribution of the active ingredient in the adhesive base layer can be increased with the liner 佃 J.
[0033] [実施の形態 1] [Embodiment 1]
図 1は本発明に係るプラスターの製造装置の実施の形態 1を示す概略構成説明図 、図 2はプラスターの概略構成説明断面図である。  FIG. 1 is a schematic structural explanatory view showing Embodiment 1 of a plaster manufacturing apparatus according to the present invention, and FIG. 2 is a schematic structural explanatory sectional view of a plaster.
まず図 2において、プラスター P1は、支持体 2と、有効成分を含有する粘着剤層 4と 、ライナー 3とがこの順に積層され、使用時にライナー 3を剥離して粘着剤層 4を被貼 付け面 (皮膚面)に貼り付け可能に構成されている(例えば、全体の大きさ:約 70mm X約 100mm)。 First, in FIG. 2, plaster P1 includes a support 2 and an adhesive layer 4 containing an active ingredient. The liner 3 is laminated in this order, and the liner 3 is peeled off during use, and the adhesive layer 4 can be applied to the surface to be applied (skin surface) (for example, the overall size: approximately 70 mm). X about 100mm).
[0034] 支持体 2はポリエステル製の不織布からなる(支持体の厚み:約 lmm)。ライナー 3 は PETに剥離剤を適宜塗布した剥離可能な合成樹脂シートからなる(ライナーの厚 み:約30〜60 111)。  [0034] The support 2 is made of a non-woven fabric made of polyester (support thickness: approximately 1 mm). Liner 3 is made of a peelable synthetic resin sheet with appropriate release agent applied to PET (liner thickness: about 30-60 111).
粘着剤層 4はホットメルト系粘着剤としてのゴム系粘着剤である、スチレン一イソプレ ンースチレン樹脂(SIS)に有効成分として医薬成分のホルモン剤(インシュリン)(約 4 00 μ g)を含有させてなる(粘着剤層の厚み:約 100〜200 μ m)。  Adhesive layer 4 contains a hormonal agent (insulin) (about 400 μg) as an active ingredient in styrene-isoprene-styrene resin (SIS), which is a rubber adhesive as a hot-melt adhesive. (The thickness of the pressure-sensitive adhesive layer: about 100 to 200 μm).
[0035] さて図 1において、プラスターの製造装置 1は、支持体繰出しロール 6から支持体 2 を搬送する支持体搬送手段と、ライナー繰出しロール 10からライナー 3を搬送するラ イナ一搬送手段と、搬送される支持体 2上に粘着基剤層 4aを形成する粘着基剤層形 成手段と、搬送されるライナー 3上に医薬成分担持層 5を形成する医薬成分担持層 形成手段と、支持体 2上に形成された粘着基剤層 4a上に、ライナー 3およびその上 に形成された医薬成分担持層 5を該医薬成分担持層 5側から貼り合せ、プラスター P 1とする貼り合せ手段と、この貼り合せ手段により得られたプラスター P1を卷き取るプ ラスター卷取り手段とを備えている。  In FIG. 1, the plaster manufacturing apparatus 1 includes a support transport means for transporting the support 2 from the support feed roll 6, a liner transport means for transporting the liner 3 from the liner feed roll 10, and Adhesive base layer forming means for forming the adhesive base layer 4a on the transported support 2; Pharmaceutical component support layer forming means for forming the pharmaceutical ingredient supporting layer 5 on the liner 3 to be transported; 2 on the adhesive base layer 4a formed on 2 is bonded from the side of the pharmaceutical component support layer 5 to the liner 3 and the pharmaceutical component support layer 5 formed thereon, and is a plaster P1; And plaster removing means for scraping the plaster P1 obtained by the bonding means.
[0036] 支持体搬送手段は、支持体繰出しロール 6から繰り出される支持体 2を後述する粘 着基剤層形成用主ロール 14へノーテンションで供給するノーテンション搬送ロール 7 と、この搬送ロールと主ロール 14との間のガイドロール 8とからなる。  [0036] The support transport means includes a no-tension transport roll 7 for supplying the support 2 fed from the support feed roll 6 to an adhesive base layer forming main roll 14 described later with no tension, and the transport roll. It consists of a guide roll 8 between the main roll 14.
ライナー搬送手段は、ライナー繰出しロール 10からライナー 3を繰り出し、後述する ゴムロール 17へ案内供給するガイドロール 11からなる。  The liner conveying means includes a guide roll 11 that feeds the liner 3 from the liner feed roll 10 and guides and feeds it to a rubber roll 17 described later.
[0037] 粘着基剤層形成手段は、温度調節機能を備えた第 1ロール 9および第 2ロール 12 力もなるコンマコータ 19と、ロール表面をシリコンコート処理した冷却ロール 13と、こ の冷却ロールに対接し、ロール表面をスリップ防止加工した粘着基剤層形成用主口 ール 14とからなる。そして冷却ロール 13には、熱交換的に付設され、ロール面上に 形成される粘着基剤層 4aの温度を医薬成分の活性を低下させない温度に下げる冷 却器(図示省略)を具備している。 [0038] 医薬成分担持層形成手段は、医薬成分溶解液を貯留する容器 15と、この容器の 医薬成分溶解液に一部を浸漬させたグラビアロール 16と、このグラビアロールに対 接し、対接間隙を通るライナー 3上に医薬成分担持層 5を形成するゴムロール 17とか らなる。なお、 23はグラビアロール 16のスクレーパである。 [0037] The adhesive base layer forming means includes a comma coater 19 having a first roll 9 and a second roll 12 having a temperature control function, a cooling roll 13 having a roll-coated silicon surface, and the cooling roll. And a main base 14 for forming an adhesive base layer which is in contact with the surface of the roll and is anti-slip processed. The cooling roll 13 is provided with a cooler (not shown) that is attached in a heat exchange manner and reduces the temperature of the adhesive base layer 4a formed on the roll surface to a temperature that does not reduce the activity of the pharmaceutical ingredients. Yes. [0038] The medicinal component-supporting layer forming means comprises a container 15 for storing a medicinal component solution, a gravure roll 16 partially immersed in the medicinal component solution in the container, and a gravure roll in contact with the gravure roll. It comprises a rubber roll 17 that forms a medicinal component-supporting layer 5 on a liner 3 that passes through the gap. Reference numeral 23 denotes a gravure roll 16 scraper.
貼り合せ手段は、主ロール 14に対接する副ロール 18からなる。  The laminating means comprises a sub roll 18 that contacts the main roll 14.
プラスター卷取り手段は、トルクモータ(図示省略)によりプラスター P1を卷き取る卷 取り口一ノレ 20と、二つのガイドロール 21 · 22とを備えている。  The plaster scraping means includes a scraper opening 20 for scraping the plaster P1 by a torque motor (not shown), and two guide rolls 21 and 22.
[0039] 以上の構成からなるプラスターの製造装置 1の作動を説明する。 The operation of the plaster manufacturing apparatus 1 having the above configuration will be described.
まず、支持体繰出しロール 6は、支持体 2をノーテンション搬送ロール 7およびガイド ロール 8を介してノーテンションで粘着基剤層形成用主ロール 14へ供給する。  First, the support feeding roll 6 supplies the support 2 to the main roll 14 for forming the adhesive base layer with no tension via the no tension conveying roll 7 and the guide roll 8.
第 1ローノレ 9と第 2ロール 12は、固形状態から 160〜180°Cに加熱されて溶融状態 となった SIS系粘着剤の供給を受け、この溶融状態の SIS系粘着剤を 120〜: 160°C に温度調整しながら、冷却ロール 13上に供給し、厚み:約 100 μ ΐηで展延する。冷 却ローラ 13は、展延された SIS樹脂の温度を約 2〜8°Cまで下げながら主ローラ 14に 供給される支持体 2上に粘着基剤層 4aを形成する。なお、支持体 2上に形成された 粘着基剤層 4aの表面温度を検知する図示しない赤外線センサーが設けられており、 このセンサーにより検知された温度信号は図示しないコントローラを介して冷却器の 温度を制御する様に構成されている。  The first roll 9 and the second roll 12 are supplied with the SIS pressure-sensitive adhesive that has been heated to 160 to 180 ° C. from the solid state to become a molten state, and the molten SIS pressure-sensitive adhesive 120 to 160: 160 While adjusting the temperature to ° C, supply it to the cooling roll 13 and spread it at a thickness of about 100 μΐη. The cooling roller 13 forms an adhesive base layer 4a on the support 2 supplied to the main roller 14 while lowering the temperature of the spread SIS resin to about 2 to 8 ° C. An infrared sensor (not shown) that detects the surface temperature of the adhesive base layer 4a formed on the support 2 is provided, and a temperature signal detected by this sensor is sent to the temperature of the cooler via a controller (not shown). It is comprised so that it may control.
[0040] 一方、ライナー繰出しロール 10はライナー 3をガイドロール 11を介してゴムロール 1 7へ供給し、グラビアロール 16が容器 15内の医薬成分溶解液 (インシュリンをラノリン に溶解)をゴムロール 17上のライナー 3の表面に展延し医薬成分担持層 5を形成す る。 [0040] On the other hand, the liner feeding roll 10 supplies the liner 3 to the rubber roll 17 through the guide roll 11, and the gravure roll 16 transfers the pharmaceutical ingredient solution (insulin dissolved in lanolin) in the container 15 onto the rubber roll 17. The medicine component carrying layer 5 is formed by spreading on the surface of the liner 3.
主ロール 14と副ロール 18は支持体 2上の粘着基剤層 4aにライナー 3およびその上 の医薬成分担持層 5をこの医薬成分担持層 5側から貼り合わせ、全体として支持体 2 と医薬成分を含有する粘着剤層 4とライナー 3とがこの順に積層され、使用時にライ ナー 3を剥離して粘着剤層 4を被貼付け面 (皮膚面)に貼り付け可能なプラスター P1 とする。得られたプラスタ—P1は卷取りロール 20によって卷き取られる。  The main roll 14 and the sub-roll 18 are bonded to the adhesive base layer 4a on the support 2 with the liner 3 and the pharmaceutical component support layer 5 thereon from the side of the pharmaceutical component support layer 5, and the support 2 and the pharmaceutical component as a whole. The pressure-sensitive adhesive layer 4 and the liner 3 are laminated in this order, and the liner 3 is peeled off during use to make the pressure-sensitive adhesive layer 4 a plaster P1 that can be attached to the surface to be applied (skin surface). The obtained plaster P1 is scraped off by a scraping roll 20.
[0041] このプラスター P1の粘着基剤層 4aは、医薬成分を含有させる前に予め形成され、 しかる後にその粘着基剤層 4aに医薬成分の活性を低下させない温度条件下で医薬 成分を含有させてレ、るので、医薬成分をその活性を低下させなレ、で効率よく粘着基 剤層 4aに含有(浸透)させることができる。さらに、得られたプラスターは、医薬成分が 粘着剤層 4の貼り付ける側から浸透されているので、医薬成分の濃度分布が貼り付 ける側で大きぐ従って医薬成分の効果が早くて大きい。 [0041] The adhesive base layer 4a of the plaster P1 is formed in advance before containing a pharmaceutical ingredient, Thereafter, the adhesive base layer 4a is allowed to contain the pharmaceutical ingredient under a temperature condition that does not reduce the activity of the pharmaceutical ingredient. Therefore, the adhesive base layer 4a can be efficiently used without reducing the activity of the pharmaceutical ingredient. Can be contained (penetrated). Further, since the obtained plaster is penetrated from the side where the adhesive layer 4 is applied, the concentration distribution of the pharmaceutical component is large on the side where the adhesive is applied, so the effect of the pharmaceutical component is fast and large.
[0042] [実施の形態 2]  [0042] [Embodiment 2]
図 3は本発明に係るプラスターの製造装置の実施の形態 2を示す概略構成説明図 、図 4はプラスターの概略構成説明断面図である。なお、実施の形態 1と同様の構成 には同じ番号を付している。  FIG. 3 is a schematic structural explanatory view showing Embodiment 2 of the plaster manufacturing apparatus according to the present invention, and FIG. 4 is a schematic structural explanatory sectional view of the plaster. The same components as those in Embodiment 1 are given the same numbers.
[0043] 図 4において、プラスター P2は、支持体 32と、有効成分を含有する粘着剤層 34と、 ライナー 33とがこの順に積層され、使用時にライナー 33を剥離して粘着剤層 34を被 貼付け面 (皮膚面)に貼り付け可能に構成されている(例えば、全体の大きさ:約 70m m X約 100mm)。  In FIG. 4, the plaster P2 includes a support 32, an adhesive layer 34 containing an active ingredient, and a liner 33, which are laminated in this order, and the liner 33 is peeled off during use to cover the adhesive layer 34. It is configured so that it can be attached to the application surface (skin surface) (for example, overall size: about 70 mm × about 100 mm).
支持体 32はポリエステル製の不織布からなる(支持体の厚み:約 lmm)。ライナー 33は合成紙に目止剤や剥離剤を適宜浸み込ませた剥離可能な合成シートからなる (ライナーの厚み:約 30〜60 μ m)。  The support 32 is made of a non-woven fabric made of polyester (support thickness: about 1 mm). The liner 33 is made of a peelable synthetic sheet in which a sealing agent or a release agent is appropriately immersed in a synthetic paper (liner thickness: about 30 to 60 μm).
粘着剤層 34はホットメルト系粘着剤としての SIS系粘着剤に有効成分として細胞賦 活成分のュビデカレン (約 300 μ g)を含有させてなる(粘着剤層の厚み:約 100〜2 00 x m)。  Adhesive layer 34 contains SIS-based adhesive as a hot-melt adhesive containing cell activation component ubidecaren (approximately 300 μg) as an active ingredient (adhesive layer thickness: approximately 100–200 xm). ).
[0044] さて図 3において、プラスターの製造装置 31は、支持体繰出しロール 6から支持体 32を搬送する支持体搬送手段と、ライナー繰出しロール 10からライナー 33を搬送す るライナー搬送手段と、搬送される支持体 32上に粘着基剤層 34aを形成する粘着基 剤層形成手段と、形成された粘着基剤層 34a上に医薬成分溶解液を塗布する医薬 成分塗布手段と、医薬成分を塗布された粘着基剤層 34a上にライナー 33を貼り合せ 、プラスター P2とする貼り合せ手段と、この貼り合せ手段により得られたプラスター P2 を卷き取るプラスター卷取り手段とを備えている。  In FIG. 3, the plaster manufacturing apparatus 31 includes a support transport means for transporting the support 32 from the support feed roll 6, a liner transport means for transporting the liner 33 from the liner feed roll 10, and a transport. An adhesive base layer forming means for forming an adhesive base layer 34a on the support 32, a pharmaceutical ingredient applying means for applying a pharmaceutical ingredient solution on the formed adhesive base layer 34a, and a pharmaceutical ingredient are applied. A liner 33 is bonded to the adhesive base layer 34a thus formed to form a plaster P2, and a plaster scraping unit for scraping the plaster P2 obtained by the bonding means.
[0045] 支持体搬送手段と粘着基剤層形成手段とは、実施の形態 1の場合と同様であり、 説明を省略する。 ライナー搬送手段は、ライナー卷回ロール 10からなり、ライナー 33を繰り出し、後述 するゴムロール 38へ案内供給する。 [0045] The support conveying means and the adhesive base layer forming means are the same as in the first embodiment, and a description thereof will be omitted. The liner conveying means includes a liner winding roll 10, which feeds out the liner 33 and guides and supplies it to a rubber roll 38 to be described later.
医薬成分塗布手段は、医薬成分溶解液を貯留する容器 15と、この容器の医薬成 分溶解液に一部を浸漬させ、粘着基剤層形成手段により支持体 32上に形成された 粘着基剤層 34aの表面に医薬成分溶解液を塗布するグラビアロール 16と、このダラ ビアロールに対接するゴムロール 36とからなる。なお、 23はグラビアロール 16のスク レーパである。  The medicinal component application means includes a container 15 for storing the medicinal component solution, and an adhesive base formed on the support 32 by the adhering base layer forming means by partially immersing the medicinal component solution in the container. It consists of a gravure roll 16 for applying a pharmaceutical component solution on the surface of the layer 34a, and a rubber roll 36 that comes into contact with this daravia roll. 23 is a gravure roll 16 scraper.
[0046] 貼り合せ手段は、対接する一対のゴムローラ 37 · 38からなり、医薬成分溶解液を塗 布された粘着基剤層 34a上にライナー 33を貼り合せる。  [0046] The laminating means is composed of a pair of rubber rollers 37 and 38 that are in contact with each other, and the liner 33 is pasted onto the adhesive base layer 34a coated with the pharmaceutical component solution.
プラスター卷取り手段は、トルクモータ(図示省略)によりプラスター P2を卷き取る卷 取りロール 20からなる。なお、 35は、支持体 32上に粘着基剤層 34aを形成した積層 体を通過させ、少なくとも粘着基剤層 34aの温度を下げる冷却部としての冷却室であ る。  The plaster scraping means comprises a scraping roll 20 that scrapes the plaster P2 by a torque motor (not shown). Reference numeral 35 denotes a cooling chamber serving as a cooling section that allows a laminate in which the adhesive base layer 34a is formed on the support 32 to pass therethrough and lowers the temperature of at least the adhesive base layer 34a.
[0047] 以上の構成からなるプラスターの製造装置 31の作動を説明する。  The operation of the plaster manufacturing apparatus 31 having the above configuration will be described.
まず、支持体繰出しロール 6は、支持体 32をノーテンション搬送ロール 7およびガイ ドロール 8を介してノーテンションで粘着基剤層形成用主ロール 14へ供給する。 第 1ローノレ 9と第 2ロール 12は、固形状態から 160〜180°Cに加熱されて溶融状態 となった SIS系粘着剤の供給を受け、この溶融状態の SIS系粘着剤を 120〜160°C に温度調整しながら、冷却ロール 13上に供給し厚み:約 100 x mで展延する。冷却 ローラ 13は、展延された SIS樹脂の温度を約 45°Cまで下げながら、主ローラ 14に供 給される支持体 2上に粘着基剤層 34aを形成する。  First, the support feeding roll 6 supplies the support 32 to the main roll 14 for forming the adhesive base layer with no tension via the no tension conveying roll 7 and the guide roll 8. The first roll 9 and the second roll 12 are supplied with the SIS pressure-sensitive adhesive that has been heated to 160 to 180 ° C from the solid state to become molten, and the SIS pressure-sensitive adhesive in the molten state is 120 to 160 °. While adjusting the temperature to C, it is supplied onto the cooling roll 13 and spreads at a thickness of about 100 xm. The cooling roller 13 forms an adhesive base layer 34a on the support 2 supplied to the main roller 14 while lowering the temperature of the spread SIS resin to about 45 ° C.
[0048] グラビアロール 16は、容器 15内の医薬成分溶解液を、支持体 32上の粘着基剤層 34aの表面に塗布する。 [0048] The gravure roll 16 applies the pharmaceutical component solution in the container 15 to the surface of the adhesive base layer 34a on the support 32.
対接する一対のゴムローラ 37 · 38は、医薬成分溶解液を塗布された粘着基剤層 3 4a上にライナー 33を貼り合せ、全体として、支持体 32と、医薬成分を含有する粘着 剤層 34と、ライナー 33とがこの順に積層され、使用時にライナー 33を剥離して粘着 剤層 34を被貼付け面 (皮膚面)に貼り付け可能なプラスター P2とする。得られたブラ スター P2は卷取りロール 20によって卷き取られる。 このプラスター P2の粘着基剤層 34aは、医薬成分を含有させる前に予め形成され、 しかる後にその粘着基剤層 34aに医薬成分の活性を低下させない温度条件下で医 薬成分を含有させてレ、るので、医薬成分をその活性を低下させなレ、で効率よく粘着 基剤層 34aにほぼ均等に含有(浸透 ·拡散)させることができる。また必要に応じて医 薬成分が粘着剤層 34の貼り付ける側から浸透しているので、医薬成分の濃度分布 を貼り付ける側で大きくすることもでき、従って医薬成分の効果が早くて大きいものを 作ること力 Sできる。 A pair of rubber rollers 37 and 38 that are in contact with each other are bonded to a liner 33 on an adhesive base layer 34a coated with a pharmaceutical component solution, and as a whole, a support 32 and an adhesive layer 34 containing a pharmaceutical component The liner 33 and the liner 33 are laminated in this order, and the liner 33 is peeled off during use, and the adhesive layer 34 is a plaster P2 that can be attached to the surface to be applied (skin surface). The obtained blaster P2 is scraped off by a scraping roll 20. The adhesive base layer 34a of this plaster P2 is formed in advance before containing the pharmaceutical ingredient, and then the adhesive base layer 34a is added with the pharmaceutical ingredient under a temperature condition that does not reduce the activity of the pharmaceutical ingredient. Therefore, the medicinal component can be contained (permeated / diffused) almost evenly and efficiently in the adhesive base layer 34a without reducing its activity. In addition, since the medicinal components permeate from the side where the adhesive layer 34 is applied as necessary, the concentration distribution of the medicinal components can be increased on the adhering side, so that the effect of the medicinal components is fast and large. The power to make S.

Claims

請求の範囲 The scope of the claims
[1] 支持体と、有効成分を含有または担持する粘着剤層と、ライナーとがこの順に積層 されたプラスターを製造する方法であって、  [1] A method for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order,
支持体またはライナー上に粘着剤の種類に応じて加熱して粘着剤自体の溶融また は使用した溶剤の蒸発によって粘着基剤層を形成し、その粘着基剤層に該有効成 分を含有または担持させることによりプラスターを連続的に得ることよりなり、  An adhesive base layer is formed on the support or liner by heating depending on the type of the adhesive to melt the adhesive itself or evaporating the solvent used, and the adhesive base layer contains the effective component or Consisting of continuously obtaining plaster by carrying,
前記粘着基剤層への有効成分の含有または担持が、粘着基剤層の形成時にした 加熱の温度を有効成分の活性を低下させない温度にまで降下させた状態で行われ るプラスターの製造方法。  A method for producing a plaster, wherein the active ingredient is contained or supported on the adhesive base layer in a state where the temperature of heating performed at the time of forming the adhesive base layer is lowered to a temperature that does not reduce the activity of the active ingredient.
[2] 支持体またはライナー上への粘着基剤層の形成に際して、該粘着基剤層の形成 時にした加熱の温度を有効成分の活性を低下させない温度にまで降下させた状態 で行われる請求項 1に記載のプラスターの製造方法。 [2] The formation of the pressure-sensitive adhesive base layer on the support or the liner is performed in a state where the heating temperature at the time of forming the pressure-sensitive adhesive base layer is lowered to a temperature that does not decrease the activity of the active ingredient. A method for producing the plaster according to 1.
[3] 前記粘着基剤層への有効成分の含有または担持が、予め有効成分含有層を形成 したライナーを支持体上に形成された粘着基剤層に貼り合わせることにより行われる 請求項 1または 2に記載のプラスターの製造方法。 [3] The active ingredient is contained in or supported on the adhesive base layer by pasting a liner on which the active ingredient-containing layer has been formed in advance to the adhesive base layer formed on the support. 2. A method for producing a plaster according to 2.
[4] 前記粘着基剤層への有効成分の含有または担持が、有効成分を溶解または分散 した溶液を粘着基剤層上に塗布することにより行われる請求項 1または 2に記載のプ ラスターの製造方法。 [4] The plaster according to claim 1 or 2, wherein the active ingredient is contained or supported on the adhesive base layer by applying a solution in which the active ingredient is dissolved or dispersed on the adhesive base layer. Production method.
[5] 前記溶液が、粘着基剤層と親和性または相溶性を有する媒体により有効成分を溶 解または分散してなる請求項 4に記載のプラスターの製造方法。  5. The method for producing a plaster according to claim 4, wherein the solution is obtained by dissolving or dispersing an active ingredient in a medium having affinity or compatibility with the adhesive base layer.
[6] 前記粘着基剤層が、ホットメルト系粘着剤で構成されている請求項 1〜5のいずれ 力 1つに記載のプラスターの製造方法。 [6] The method for producing a plaster according to any one of [1] to [5], wherein the adhesive base layer is composed of a hot-melt adhesive.
[7] 前記粘着基剤層が、その厚みを 10〜: 1000 /i mとしてなる請求項 1〜6のいずれか[7] The adhesive base layer according to any one of claims 1 to 6, wherein the thickness of the adhesive base layer is 10 to 1000 / im.
1つに記載のプラスターの製造方法。 The manufacturing method of the plaster as described in one.
[8] 前記支持体がポリエステル繊維からなる織布、前記ライナーがポリエチレンテレフタ レートフィルムである請求項 1〜7のいずれか 1つに記載のプラスターの製造方法。 [8] The method for producing a plaster according to any one of [1] to [7], wherein the support is a woven fabric made of polyester fiber, and the liner is a polyethylene terephthalate film.
[9] 前記有効成分の活性を低下させない温度が、約 35〜約 100°Cである請求項 1〜8 のいずれか 1つに記載のプラスターの製造方法。 [9] The method for producing a plaster according to any one of [1] to [8], wherein the temperature at which the activity of the active ingredient is not lowered is about 35 to about 100 ° C.
[10] 前記有効成分の活性を低下させない温度が、約 35〜約 80°Cである請求項:!〜 8 のいずれか 1つに記載のプラスターの製造方法。 [10] The method for producing a plaster according to any one of [8] to [8], wherein the temperature at which the activity of the active ingredient is not lowered is about 35 to about 80 ° C.
[11] 請求項 3〜: 10のいずれ力 1つに記載のプラスターの製造方法によって得られ、粘 着剤層の有効成分の濃度分布がライナー側で大きいことを特徴とするプラスター。 [11] A plaster obtained by the method for producing a plaster according to any one of claims 3 to 10, wherein the concentration distribution of the active ingredient in the adhesive layer is large on the liner side.
[12] 支持体と、有効成分を含有または担持する粘着剤層と、ライナーとがこの順に積層 されたプラスターを製造する装置であって、  [12] An apparatus for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order,
支持体を搬送する支持体搬送手段と、  A support transport means for transporting the support;
ライナーを搬送するライナー搬送手段と、  Liner conveying means for conveying the liner;
搬送される支持体とライナーのいずれか一方上に粘着基剤層を形成する粘着基剤 層形成手段と、  An adhesive base layer forming means for forming an adhesive base layer on either the support or the liner to be conveyed;
搬送される支持体とライナーのいずれか他方上に有効成分含有層を形成すること により有効成分担持層を形成する有効成分担持層形成手段と、  An active ingredient-carrying layer forming means for forming an active ingredient-carrying layer by forming an active ingredient-containing layer on the other of the carrier and the liner to be conveyed;
前記粘着基剤層の温度を検知する温度検知手段と、  Temperature detecting means for detecting the temperature of the adhesive base layer;
この温度検知手段によって検知された温度が有効成分の活性を低下させない温度 にまで降下した状態で、前記粘着基剤層の表面に前記有効成分担持層を貼り合わ せ、有効成分を粘着基剤層に含有または担持させる粘着基剤層と有効成分担持層 との貼り合せ手段と  In a state where the temperature detected by the temperature detection means has dropped to a temperature that does not reduce the activity of the active ingredient, the active ingredient-supporting layer is bonded to the surface of the adhesive base layer, and the active ingredient is then added to the adhesive base layer. Means for adhering the adhesive base layer to be contained or carried in the active ingredient and the active ingredient carrying layer;
を備えてなるプラスターの製造装置。  A plaster manufacturing apparatus comprising:
[13] 支持体と、有効成分を含有または担持する粘着剤層と、ライナーとがこの順に積層 されたプラスターを製造する装置であって、 [13] An apparatus for producing a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order,
支持体を搬送する支持体搬送手段と、  A support transport means for transporting the support;
ライナーを搬送するライナー搬送手段と、  Liner conveying means for conveying the liner;
搬送される支持体とライナーのいずれか一方上に粘着基剤層を形成する粘着基剤 層形成手段と、  An adhesive base layer forming means for forming an adhesive base layer on either the support or the liner to be conveyed;
前記粘着基剤層の温度を検知する温度検知手段と、  Temperature detecting means for detecting the temperature of the adhesive base layer;
形成された粘着基剤層上に、前記温度検知手段によって検知された温度が有効 成分の活性を低下させなレ、温度にまで降下した状態で、有効成分を溶解または分 散した溶液を塗布し、有効成分を粘着基剤層に含有または担持させる有効成分塗 布手段と、 On the formed adhesive base layer, a solution in which the active ingredient is dissolved or dispersed is applied in a state where the temperature detected by the temperature detecting means has decreased to the temperature without reducing the activity of the active ingredient. Active ingredient coating containing or supporting active ingredient in adhesive base layer Cloth means;
有効成分を含有または担持した粘着基剤層上に支持体とライナーのいずれか他方 を貼り合わせる貼り合せ手段と  A laminating means for laminating either the support or the liner on the adhesive base layer containing or carrying the active ingredient;
を備えてなるプラスターの製造装置。  A plaster manufacturing apparatus comprising:
[14] 前記粘着基剤層と前記有効成分担持層とを貼り合せる前に、粘着基剤層を有効成 分の活性を低下させない温度に調整する温度調整手段を更に備えた請求項 12に記 載のプラスターの製造装置。 [14] The device according to claim 12, further comprising temperature adjusting means for adjusting the pressure-sensitive adhesive layer to a temperature that does not decrease the activity of the effective component before the pressure-sensitive adhesive base layer and the active ingredient-carrying layer are bonded to each other. Production equipment for plaster.
[15] 前記粘着基剤層に有効成分を溶解または分散した溶液を塗布する前に、粘着基 剤層を有効成分の活性を低下させない温度に調整する温度調整手段を更に備えた 請求項 13に記載のプラスターの製造装置。 [15] The apparatus of claim 13, further comprising a temperature adjusting means for adjusting the pressure-sensitive adhesive layer to a temperature that does not decrease the activity of the active ingredient before applying a solution in which the active ingredient is dissolved or dispersed in the pressure-sensitive adhesive base layer. The manufacturing apparatus of the plaster of description.
[16] 前記温度検出手段が、非接触型の赤外線サーモセンサである請求項 12〜: 15のい ずれか 1つに記載のプラスターの製造装置。 [16] The plaster manufacturing apparatus according to any one of [12] to [15], wherein the temperature detection means is a non-contact infrared thermosensor.
[17] 前記粘着基剤層形成手段が、供給される高温の粘着剤をロール面上に展延して 粘着基剤層とする粘着基剤層形成ロールと、搬送される支持体とライナーのいずれ 力一方上に前記粘着基剤層を貼り合せる貼り合せロールとからなり、 [17] An adhesive base layer forming roll in which the adhesive base layer forming means spreads the supplied high-temperature adhesive on the roll surface to form an adhesive base layer; It consists of a laminating roll for laminating the adhesive base layer on one side,
前記温度調整手段が、前記貼り合せロールに熱交換的に付設され、前記粘着基 剤層の温度を有効成分の活性を低下させない温度に下げる冷却器である請求項 14 に記載のプラスターの製造装置。  15. The plaster manufacturing apparatus according to claim 14, wherein the temperature adjusting means is a cooler that is attached to the laminating roll in a heat exchange manner and reduces the temperature of the adhesive base layer to a temperature that does not decrease the activity of the active ingredient. .
[18] 前記温度調整手段が、搬送される支持体とライナーのいずれか一方とその上に形 成された粘着基剤層とを通過させることにより少なくとも粘着基剤層の温度を有効成 分の活性を低下させない温度に下げる冷却部である請求項 14または 15に記載のプ ラスターの製造装置。 [18] The temperature adjusting means allows at least the temperature of the adhesive base layer to be an effective component by passing either the support to be conveyed or the liner and the adhesive base layer formed thereon. 16. The apparatus for producing a plaster according to claim 14, wherein the apparatus is a cooling section that lowers the temperature to a temperature that does not decrease the activity.
[19] 支持体と、有効成分を含有または担持する粘着剤層と、ライナーとがこの順に積層 されたプラスターにおレ、て用いられるライナーであって、  [19] A liner used for a plaster in which a support, an adhesive layer containing or carrying an active ingredient, and a liner are laminated in this order,
粘着基剤層に貼り合わせにより有効成分を含有または担持させるための有効成分 含有層を予めライナー上に形成したプラスター用ライナー。  A plaster liner in which an active ingredient-containing layer is formed on a liner in advance for containing or carrying an active ingredient by bonding to an adhesive base layer.
[20] 前記有効成分含有層が、粘着基剤層と親和性または相溶性を有する媒体により有 効成分を溶解または分散した溶液をライナー上に塗布することによって形成された請 求項 19に記載のプラスター用ライナー。 [20] The coating formed by applying a solution in which the active ingredient is dissolved or dispersed in a medium having an affinity or compatibility with the adhesive base layer on the liner. The plaster liner according to claim 19.
PCT/JP2006/316266 2005-08-19 2006-08-18 Process for producing plaster, apparatus for producing the same, and liner for plaster WO2007021008A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007531044A JP4913738B2 (en) 2005-08-19 2006-08-18 Plaster manufacturing method and apparatus, and plaster liner

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005238540 2005-08-19
JP2005-238540 2005-08-19

Publications (1)

Publication Number Publication Date
WO2007021008A1 true WO2007021008A1 (en) 2007-02-22

Family

ID=37757661

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/316266 WO2007021008A1 (en) 2005-08-19 2006-08-18 Process for producing plaster, apparatus for producing the same, and liner for plaster

Country Status (2)

Country Link
JP (1) JP4913738B2 (en)
WO (1) WO2007021008A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008206577A (en) * 2007-02-23 2008-09-11 Tanida Co Ltd Adhesive plaster with function for removing wrinkle and fleck on skin and its manufacturing method
JP2014028767A (en) * 2012-07-31 2014-02-13 Lion Corp Patch

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06327756A (en) * 1993-05-25 1994-11-29 Sekisui Chem Co Ltd Production of air permeable tacky adhesive tape
JPH08295624A (en) * 1995-04-26 1996-11-12 Read Chem Kk Plaster base, its production and patch for external use using the same base

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61251619A (en) * 1985-04-30 1986-11-08 Nitto Electric Ind Co Ltd Nicotin-containing tape preparation
DE3629304A1 (en) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg TRANSDERMAL THERAPEUTIC SYSTEM, ITS USE AND METHOD FOR THE PRODUCTION THEREOF
DE4332094C2 (en) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Active substance plaster which can be produced without solvent and process for its preparation
WO1995031190A1 (en) * 1994-05-18 1995-11-23 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable preparation for treating urination disorder

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06327756A (en) * 1993-05-25 1994-11-29 Sekisui Chem Co Ltd Production of air permeable tacky adhesive tape
JPH08295624A (en) * 1995-04-26 1996-11-12 Read Chem Kk Plaster base, its production and patch for external use using the same base

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008206577A (en) * 2007-02-23 2008-09-11 Tanida Co Ltd Adhesive plaster with function for removing wrinkle and fleck on skin and its manufacturing method
JP2014028767A (en) * 2012-07-31 2014-02-13 Lion Corp Patch

Also Published As

Publication number Publication date
JP4913738B2 (en) 2012-04-11
JPWO2007021008A1 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
EP1061900B2 (en) Dermal compositions
AU2004285505B2 (en) Transdermal drug delivery device
CA2865715C (en) Transdermal patch
WO2008044336A1 (en) Crystal-containing adhesive preparation
WO2005117886A1 (en) Adhesive patch
JP2006206471A (en) Tape preparation
US20170112781A1 (en) Transdermal drug delivery systems with polyisobutylene face adhesive
JP4924837B2 (en) Transdermal absorption preparation
JPH08193030A (en) Emedastine cataplasm preparation
JP2004115774A (en) Pasting sheet or tape
WO2013047410A1 (en) Long-acting adhesive skin patch for treating alzheimer's disease, and method for producing same
JP4913738B2 (en) Plaster manufacturing method and apparatus, and plaster liner
EP1352649B1 (en) Patch and production method thereof
EP3744321B1 (en) Patch
JP4647490B2 (en) Tulobuterol-containing patch
JP2007070247A (en) Percutaneous absorption-type preparation
JP2003104875A (en) Device for slow release medicine
JP2016037464A (en) Galanthamine containing percutaneous absorption preparation
WO2010073327A1 (en) Patch
CN108685877A (en) With the patch system for percutaneous absorbtion for minimizing skin irritatin
JP2013132367A (en) Patch preparation
JP2019001740A (en) Transdermal preparation
EP3744322B1 (en) Patch
WO2018199015A1 (en) Transdermally absorbable preparation and method for producing same
CN117752636A (en) Brivaracetam reservoir type transdermal patch, and preparation method and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007531044

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06782825

Country of ref document: EP

Kind code of ref document: A1